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ABSTRACT	  
	  
Salmonella	  enterica	  serovar	  Saintpaul	  (SstpNPG)	  is	  a	  unique	  isolate	  capable	  of	  producing	  bovine	  encephalopathy	  in	  the	  presence	  of	  host	  neuroendocrine	  hormones.	  In	  
vivo	  and	  in	  vitro	  molecular	  techniques	  were	  used	  to	  determine	  how	  specific	  the	  conditions	  are	  for	  the	  perpetuation	  of	  neuropathogenicity,	  to	  understand	  how	  the	  strain	  traversed	  the	  blood-­‐brain	  barrier	  (BBB),	  to	  find	  a	  potential	  pharmacological	  agent	  that	  abrogated	  the	  effects	  of	  neuropathogenicity,	  and	  to	  assess	  the	  bacterial	  factors	  that	  provoke	  neurologic	  disease.	  	  In	  order	  to	  determine	  if	  collagenase	  (clg)	  is	  responsible	  for	  the	  traversal	  of	  the	  BBB,	  RT-­‐PCRs	  were	  conducted	  to	  determine	  clg	  expression.	  	  Results	  elucidated	  a	  unique	  relationship	  between	  bovine	  stress	  factors	  and	  clg	  that	  could	  be	  abrogated	  by	  cilostazol,	  which	  is	  capable	  of	  tightening	  the	  BBB.	  	  Knock	  out	  of	  clg	  also	  abolished	  signs	  of	  neurologic	  disease	  in	  calves.	  	  It	  was	  also	  established	  that	  these	  neurologic	  deficits	  seen	  in	  cattle	  could	  not	  be	  reproduced	  in	  swine.	  	  In	  order	  to	  determine	  if	  these	  signs	  of	  neurologic	  disease	  could	  be	  abolished,	  beta-­‐lactam	  antibiotics,	  which	  has	  been	  recently	  determined	  as	  a	  novel	  neuroprotective	  agent	  through	  the	  upregulation	  of	  glutamate	  transporter	  expression,	  were	  given	  as	  a	  treatment	  and	  successfully	  ameliorated	  bovine	  encephalopathy	  indicating	  excess	  extracellular	  glutamate	  as	  a	  key	  component.	  	  Since	  little	  CNS	  inflammation	  occurred,	  neurologic	  disease	  most	  likely	  resulted	  from	  signal	  transduction	  aberrations.	  	  Lipopolysaccharides	  (LPS)	  could	  be	  possible	  elements	  that	  provoke	  such	  effects.	  	  Considering	  this,	  LPS	  was	  blocked	  and/or	  debilitated	  pharmacologically,	  resulting	  in	  no	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CHAPTER	  1.	  	  OVERVIEW	  	  INTRODUCTION	  
Salmonella	  are	  Gram-­‐negative,	  rod-­‐shaped	  bacteria	  possessing	  peritrichous	  flagella	  for	  motility.	  	  	  These	  facultative	  anaerobes	  are	  capable	  of	  producing	  ATP	  through	  aerobic	  respiration	  if	  oxygen	  is	  present	  but	  are	  also	  able	  to	  switch	  to	  fermentation	  in	  its	  absence.	  	  They	  also	  obtain	  energy	  from	  organic	  compound	  sources	  such	  as	  glucose,	  categorizing	  them	  as	  chemoorganotrophs.	  	  The	  genus	  Salmonella	  is	  comprised	  of	  two	  species	  that	  are	  95-­‐99%	  homologous	  on	  a	  DNA	  level,	  S.	  bongori	  and	  S.	  enterica	  [18].	  	  S.	  
enterica	  can	  be	  furthered	  delineated	  into	  six	  subspecies	  [9].	  	  Subspecies	  enterica	  (I)	  is	  mostly	  isolated	  from	  avian	  species	  and	  mammals,	  while	  S.	  	  bongori	  and	  S.	  enterica	  subspecies	  salamae	  (II),	  arizonae	  (IIIa),	  diarizonae	  (IIIb),	  houtenae	  (IV),	  and	  indica	  (VI)	  are	  typically	  found	  in	  cold-­‐blooded	  vertebrates	  [7,	  14].	  	  	  	  Demarcation	  into	  serotypes	  derive	  from	  variance	  found	  within	  the	  O	  antigen	  of	  the	  lipopolysaccharide	  (LPS),	  the	  H	  antigen	  of	  the	  flagella,	  and	  oftentimes	  the	  capsular	  polysaccharides	  (Vi)	  antigens	  using	  the	  Kauffman-­‐White	  scheme	  [9,	  14,	  34].	  	  	  Subtyping	  of	  Salmonella	  strains	  are	  conducted	  through	  the	  following	  molecular	  techniques:	  pulsed-­‐field	  gel	  electrophoresis,	  amplified	  fragment	  length	  polymorphism,	  ribotyping	  and	  multi-­‐locus	  sequence	  typing	  [1,	  39].	  	  Plasmid	  profiling,	  arbitrarily	  primed	  polymerase	  chain	  reaction	  (PCR)	  fingerprinting,	  and	  repetitive-­‐sequence-­‐based	  PCR	  fingerprinting	  techniques	  are	  also	  used	  to	  identify	  strains	  into	  serotypes	  [2].	  	  Specifically,	  serotypes	  phenotypically	  characterize	  strains	  based	  on	  the	  immunologic	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reactivity	  of	  O,	  H,	  and	  Vi	  antigens.	  	  Determining	  the	  species	  and	  subspecies	  into	  which	  a	  strain	  falls	  through	  serotyping	  is	  important	  for	  better	  investigation	  of	  outbreaks	  because	  certain	  diseases	  or	  epidemiology	  is	  often	  in	  association	  with	  certain	  serovars.	  
S.	  enterica	  serovar	  Saintpaul	  (Sstp)	  is	  an	  uncommon	  serotype	  and	  has	  only	  been	  reported	  as	  a	  bacterial	  strain	  of	  infection	  in	  1.6%	  of	  cases	  annually	  [19].	  	  	  This	  strain	  is	  typically	  associated	  with	  foodborne	  illnesses	  resulting	  from	  meat	  consumption.	  	  Recently,	  Sstp	  has	  been	  implicated	  in	  Salmonella	  outbreaks	  from	  consumption	  of	  multiple	  fresh	  produce	  such	  as	  bean	  sprouts,	  lettuce,	  tomatoes,	  and	  melons	  [19].	  	  	  During	  the	  summer	  of	  2008,	  one	  of	  the	  largest	  Salmonella	  outbreaks	  resulted	  from	  Sstp-­‐infected	  jalapeño	  peppers	  [19].	  	  	  	  PATHOGENECITY	  OF	  SALMONELLA	  	   Salmonella	  infection	  is	  a	  result	  of	  ingesting	  food	  or	  water	  that	  has	  been	  contaminated.	  	  The	  first	  barrier	  pathogens	  have	  to	  overcome	  is	  the	  intestinal	  lining	  of	  the	  host,	  more	  specifically	  M	  (microfold)	  cells.	  	  Enterocytes	  are	  also	  infected	  by	  
Salmonella	  in	  bovines	  [27].	  	  These	  interactions	  occur	  fairly	  quickly.	  	  Frost	  and	  colleagues	  (1997)	  conducted	  experiments	  implicating	  that	  5	  minutes	  post-­‐inoculation	  resulted	  in	  bacterial	  migration	  to	  M-­‐cells	  and	  host	  response	  of	  M-­‐cell	  engulfing	  bacteria.	  	  M-­‐cells	  are	  specialized	  antigen	  epithelial	  cells	  of	  the	  follicle-­‐associated	  epithelium	  covering	  the	  domed	  villi	  of	  the	  Peyer’s	  patch	  in	  the	  small	  intestine	  and	  have	  an	  immunological	  role	  through	  the	  transportation	  of	  foreign	  material	  from	  the	  lumen	  to	  lymphoid	  tissues	  for	  the	  purpose	  of	  immunological	  sampling	  [11].	  	  Their	  role	  is	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comparable	  to	  that	  of	  immunological	  surveillance	  -­‐-­‐	  a	  feature	  often	  exploited	  by	  pathogens	  in	  order	  to	  invoke	  systemic	  effects	  [17,	  18].	  	  M-­‐cells	  are	  polarized	  and	  form	  tight	  junctions,	  delineating	  the	  apical	  and	  basolateral	  membrane	  domains	  [17].	  	  The	  apical	  membrane	  facilitates	  the	  adherence	  and	  uptake	  of	  antigens	  and	  microorganisms.	  	  Instead	  of	  possessing	  a	  brush	  border,	  it	  has	  varying	  microvilli	  integrated	  with	  large	  plasma	  membrane	  subdomains	  exposed	  to	  the	  lumen,	  which	  leads	  to	  a	  desirable	  pathway	  through	  the	  intestinal	  layer	  for	  Salmonella.	  	  The	  physical	  structure	  of	  M-­‐cells	  is	  maintained	  by	  a	  dense	  scaffold	  of	  intermediate	  filaments	  that	  form	  around	  the	  nucleus	  and	  intraepithelial	  pocket,	  a	  unique	  element	  to	  the	  cell.	  	  	  Rearranging	  the	  cytoskeletal	  structure	  of	  M-­‐cells	  induces	  the	  internalization	  of	  
Salmonella.	  	  This	  modification	  results	  in	  cytotoxicity	  and	  augments	  the	  persistence	  of	  the	  infection	  via	  contiguous	  enterocytes.	  	  Through	  modification	  of	  host	  actin	  cytoskeleton	  and	  macropinocytosis,	  Salmonella	  invade	  cells	  and	  enter	  what	  is	  referred	  to	  as	  a	  Salmonella-­‐containing	  vacuole	  (SCV)	  where	  they	  can	  proliferate	  (see	  Figure	  1).	  	  The	  generation	  of	  SCV,	  also	  known	  as	  a	  phagosome,	  is	  a	  result	  of	  bacteria	  coming	  into	  contact	  with	  the	  surface	  of	  the	  target	  host	  cell	  and	  thereby	  engulfed	  to	  form	  the	  vacuole	  [5,	  18].	  	  Specifically,	  bacteria	  attach	  to	  the	  apical	  epithelial	  surface	  which	  perpetuates	  the	  release	  of	  effector	  proteins	  that	  go	  onto	  rearrange	  the	  cytoskeleton	  to	  form	  membrane	  ruffles	  that	  then	  reach	  out	  and	  encapsulate	  the	  bacteria	  attached	  to	  the	  surface	  into	  a	  large	  vesicle,	  the	  SCV	  [25].	  	  Bacteria	  are	  confronted	  with	  nutrient-­‐limiting	  conditions,	  low	  pH,	  cationic	  peptides	  and	  reactive	  oxygen	  species	  (ROS)	  inside	  the	  SCV	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[27].	  	  The	  SCV	  then	  migrates	  to	  the	  basolateral	  membrane	  and	  the	  apical	  epithelial	  surface	  reforms.	  	  	  	  After	  traversing	  the	  intestinal	  cell,	  Salmonella	  enter	  macrophages,	  which	  occur	  either	  through	  phagocytosis	  or	  through	  the	  release	  of	  effector	  proteins	  that	  will	  then	  mediate	  bacterial	  engulfment	  [18,	  25].	  	  Bacteria	  are	  capable	  of	  being	  engulfed	  by	  macrophages	  in	  the	  lamina	  propria	  within	  60	  minutes	  [11].	  	  Survival	  within	  macrophages	  is	  essential	  for	  establishing	  systemic	  infection	  and	  for	  host	  adaptation.	  From	  this	  advantage,	  Salmonella	  can	  proliferate	  throughout	  the	  host	  with	  the	  migration	  of	  infected	  macrophages	  into	  other	  organs	  (e.g.,	  liver,	  spleen,	  and	  very	  rarely	  the	  brain)	  within	  the	  reticulo-­‐endothelial	  system.	  	  The	  ability	  to	  withstand	  the	  harsh	  environment	  of	  macrophages	  will	  be	  further	  discussed.	  	  	  	  	  	  SALMONELLOSIS	  	  Salmonellosis	  can	  manifested	  as	  gastroenteritis	  or	  systemic	  disease	  characterized	  by	  septicemia	  (i.e.,	  typhoid	  or	  paratyphoid	  fever)	  [9].	  	  On	  occasion,	  salmonellosis	  can	  also	  produce	  bacteremia,	  whereby	  bacteria	  can	  be	  isolated	  from	  the	  blood,	  often	  resulting	  in	  high	  fevers	  (distinguishable	  from	  typhoid	  fevers,	  which	  is	  continual	  throughout	  the	  infection),	  and	  is	  quickly	  cleared	  from	  the	  host	  [32].	  	  Over	  16	  million	  cases	  of	  typhoid	  fever	  have	  been	  reported	  worldwide	  each	  year,	  with	  approximately	  600,000	  fatal	  outcomes,	  and	  there	  have	  also	  been	  1.3	  billion	  incidences	  of	  gastroenteritis	  caused	  by	  non-­‐typhoidal	  salmonellosis	  resulting	  in	  3	  million	  deaths	  annually	  [13].	  	  	  In	  regard	  to	  human	  infections,	  Salmonella	  enterica	  can	  be	  categorized	  as	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either	  typhoidal	  (S.	  Typhi,	  S.	  Paratyphi	  A,	  S.	  Paratyphi	  B,	  S.	  Paratyphi	  C,	  S.	  Choleraesuis,	  and	  S.	  Sendai)	  or	  nontyphoidal	  Salmonella	  (NTS)[14].	  	  	  In	  cases	  where	  host	  immune	  responses	  are	  attenuated,	  NTS	  are	  capable	  of	  systemic	  infections,	  though	  this	  is	  typically	  uncommon.	  	  Even	  more	  rare	  is	  NTS	  that	  produces	  encephalopathy	  in	  hosts	  like	  that	  of	  a	  neuropathogenic	  strain	  of	  Sstp.	  
Typhoidal	  (enteric)	  bacterial	  infection	  	   Typhoid	  fever	  is	  a	  systemic	  disease	  that	  results	  in	  the	  colonization	  of	  the	  lymph	  nodes,	  liver,	  kidney	  and	  blood	  of	  hosts.	  	  This	  infection	  is	  caused	  by	  strains	  of	  Salmonella	  that	  are	  specific	  to	  humans	  or	  higher	  primates,	  such	  as	  Salmonella	  Typhi	  and	  Paratyphi.	  	  	  Infection	  with	  S.	  Typhi	  is	  significantly	  more	  common	  than	  with	  S.	  Paratyphi	  but	  the	  clinical	  signs	  for	  each	  are	  indistinguishable	  [28].	  	  	  In	  chronic	  cases,	  Salmonella	  can	  also	  be	  isolated	  from	  the	  gall	  bladder.	  	  Signs	  of	  this	  infection	  include	  fever,	  abdominal	  pain,	  transient	  diarrhea	  or	  constipation,	  and	  maculopapular	  rash	  [25].	  	  These	  strains	  have	  an	  incubation	  period	  lasting	  between	  5	  to	  9	  days	  and	  symptoms	  can	  subsist	  for	  three	  weeks	  [28].	  	  	  Meningitis	  and	  other	  forms	  of	  encephalopathy	  can	  also	  result	  from	  typhoidal	  bacterial	  infection,	  especially	  in	  young	  children,	  indicating	  Salmonella’s	  ability	  to	  traverse	  the	  blood-­‐brain	  barrier	  (BBB).	  	  When	  left	  untreated,	  10	  to	  15%	  cases	  of	  typhoidal	  bacterial	  infection	  end	  in	  death	  [25].	  	  As	  mentioned	  previously,	  this	  disease	  is	  typically	  specific	  to	  humans	  infected	  by	  S.	  Typhi	  and	  S.	  Paratyphi	  but	  S.	  Typhimurium	  has	  been	  demonstrated	  to	  produce	  typhoid-­‐like	  fever	  in	  mice.	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Nontyphoidal	  (gastroenteritis)	  bacterial	  infection	  	   Unlike	  typhoidal	  bacterial	  infections,	  nontyphoidal	  bacterial	  infections	  produce	  gastroenteritis	  in	  multiple	  hosts	  –	  such	  as	  avian,	  bovine	  and	  porcine	  hosts.	  	  Gastroenteritis	  can	  result	  from	  any	  of	  the	  more	  than	  2,500	  Salmonella	  serovars,	  though	  it	  is	  most	  commonly	  associated	  with	  Salmonella	  Typhimurium	  and	  Salmonella	  Enteriditis	  [32].	  	  Inflammatory	  responses	  that	  lead	  to	  intestinal	  pathology	  and	  diarrhea	  signify	  gastroenteritis	  [18].	  	  NTS	  strains	  have	  a	  brief	  incubation	  period	  lasting	  between	  12	  to	  72	  hours	  before	  the	  onset	  of	  symptoms	  occur,	  which	  typically	  lasts	  no	  longer	  than	  10	  days	  [28].	  	  The	  limited	  dissemination	  of	  infection	  is	  indicative	  of	  an	  inability	  to	  overcome	  host	  defenses	  outside	  the	  intestinal	  mucosa.	  	  	  	   	  	  	  	  Infection	  of	  cattle	  with	  S.	  Typhimurium	  typically	  results	  in	  gastroenteritis	  that	  is	  often	  signified	  by	  diarrhea.	  	  Signs	  of	  infection,	  including	  anorexia,	  fever,	  dehydration	  and	  prostration,	  typically	  occur	  within	  12	  to	  48	  hours	  [32].	  	  	  Significant	  pathological	  changes	  occur	  in	  the	  calf	  intestine	  where	  the	  lymph	  nodes	  are	  enlarged	  and	  the	  small	  intestine	  (specifically,	  caudal	  jejunum	  and	  ileum)	  is	  congested	  and	  distended	  [32].	  	  	  Increased	  neutrophil	  migration	  through	  the	  epithelium	  on	  top	  of	  Salmonella	  infiltration	  of	  neutrophils	  is	  considered	  the	  pathogenesis	  of	  diarrhea	  due	  to	  the	  event	  occurring	  prior	  to	  the	  intestinal	  lumen	  accumulating	  fluid	  [31].	  	  	  Morphologic	  changes	  result	  in	  increased	  expression	  of	  CXC	  chemokines	  (GROα,	  GROγ,	  and	  GCP2)	  and	  pro-­‐inflammatory	  cytokines	  (IL-­‐1β	  and	  IL-­‐8)	  [31].	  	  The	  enteric	  effect	  of	  S.	  Typhimurium	  in	  calves	  is	  similar	  to	  that	  of	  gastroenteritis	  in	  humans	  making	  it	  an	  ideal	  model	  to	  study.	  	  	  	  
	   7	  
VIRULENCE	  FACTORS	  The	  type	  of	  salmonellosis	  is	  determined	  by	  the	  relationship	  between	  the	  host	  and	  bacterium.	  	  	  This	  relationship	  rests	  on	  the	  ability	  to	  colonize	  and	  survive	  within	  the	  host.	  	  	  The	  pathogenesis	  of	  Salmonella	  is	  contingent	  on	  the	  ability	  to	  invade	  and	  evade	  host	  cells	  in	  order	  to	  survive	  and	  replicate	  within	  the	  environment.	  	  Virulence	  factors,	  such	  as	  virulence	  plasmids,	  toxins,	  fimbriae,	  and	  flagella	  allow	  the	  bacteria	  to	  colonize	  and	  survive	  the	  antimicrobial	  environment.	  	  Other	  virulence	  factors	  such	  as	  Salmonella	  Pathogenicity	  Islands	  (SPI),	  which	  contain	  secretion	  systems	  that	  allow	  the	  bacterium	  to	  penetrate	  phagocytic	  and	  non-­‐phagocytic	  cells,	  also	  contribute	  to	  pathogenesis	  and	  bacterial	  persistence.	  	  	  
Virulence	  plasmids	  Only	  a	  few	  serovars	  within	  subspecies	  I,	  particularly	  those	  showing	  host	  adaptation,	  have	  virulence	  plasmids	  that	  are	  essential	  to	  bacterial	  multiplication	  within	  the	  reticulo-­‐endothelial	  system	  of	  hosts	  [29].	  	  Virulence	  plasmids	  are	  identified	  by	  a	  7.8	  kb	  region	  referred	  to	  as	  spv	  (Salmonella	  plasmid	  virulence),	  which	  houses	  five	  genes	  designated	  as	  spv	  RABCD	  [38].	  	  	  Little	  is	  known	  of	  their	  function	  with	  the	  exception	  of	  
spvR.	  	  The	  regulatory	  protein	  produced	  by	  spvR	  is	  responsible	  for	  the	  expression	  of	  other	  spv	  genes.	  	  Though	  the	  plasmid	  is	  putatively	  not	  involved	  in	  the	  enteric	  stages	  of	  disease,	  Libby	  and	  colleagues	  (1997)	  demonstrated	  that	  it	  does	  play	  a	  role	  in	  the	  severity	  of	  the	  enteric	  disease.	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Toxins	  There	  are	  also	  two	  forms	  of	  toxins	  that	  aid	  in	  the	  success	  of	  bacterial	  invasion:	  endotoxins	  and	  exotoxins.	  	  Table	  1	  addresses	  additional	  differences	  between	  these	  two	  virulence	  factors.	  	  Endotoxins	  are	  found	  imbedded	  in	  the	  outer	  membrane	  of	  Gram-­‐negative	  bacteria	  and	  most	  is	  often	  synonymous	  with	  LPS	  but	  any	  cell-­‐associated	  bacterial	  toxin	  can	  be	  considered	  as	  such.	  	  Endotoxins	  can	  have	  an	  effect	  through	  release,	  which	  may	  occur	  during	  growth	  or	  bacterial	  lysis,	  or	  by	  remaining	  attached	  to	  the	  cell	  membrane	  and	  interacting	  with	  the	  host	  receptors.	  	  The	  toxicity	  of	  LPS	  typically	  results	  from	  the	  ability	  of	  lipid	  A	  to	  perpetuate	  potent	  and	  noxious	  immune	  responses,	  such	  as	  the	  release	  of	  cytokines	  [tumor	  necrosis	  factor-­‐α	  (TNF-­‐α)	  and	  interleukin-­‐1β	  (IL-­‐1β)]	  and	  mammalian	  inducible	  nitric	  oxide	  synthase	  (iNOS).	  	  The	  release	  of	  these	  pro-­‐inflammatory	  mediators	  is	  an	  indication	  of	  endotoxins	  causing	  harm	  to	  the	  host	  during	  salmonellosis	  while	  still	  attached	  to	  live	  bacteria	  [16].	  	  	  Exotoxins	  are	  proteins	  (usually	  toxic)	  that	  modify	  the	  host	  environment	  and	  cell	  functions,	  such	  as	  cytoskeleton	  dynamics,	  vesicular	  trafficking,	  morphology	  of	  host	  plasma	  membrane,	  and	  immune	  responses	  in	  order	  to	  gain	  entry	  into	  targeted	  cells	  [33,	  36].	  	  	  Exotoxins	  are	  considered	  either	  cytotoxins	  or	  enterotoxins	  [38]	  and	  are	  distributed	  through	  a	  simple	  release	  into	  the	  cytoplasm,	  delivered	  to	  the	  target	  cell	  under	  the	  guidance	  of	  a	  chaperone	  protein	  or	  via	  protein	  secretion	  systems,	  such	  as	  type	  III	  secretion	  systems	  (T3SS)	  or	  type	  IV	  secretion	  systems	  (T4SS)	  that	  deliver	  the	  bacterial	  toxins	  in	  a	  spatial	  and	  temporal	  fashion	  [33].	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Protein	  Secretion	  Systems	  and	  SPIs	  Seven	  different	  types	  of	  protein	  secretion	  systems	  (types	  I	  –	  VII)	  have	  been	  identified	  in	  Salmonella	  enterica	  [21].	  	  T3SSs	  resemble	  that	  of	  a	  molecular	  syringe	  that	  delivers	  virulence	  proteins	  capable	  of	  manipulating	  host-­‐cell	  functions	  (signal	  transduction,	  cytoskeletal	  rearrangement,	  membrane	  trafficking,	  and	  cytokine	  expression)	  for	  bacterial	  survival	  and	  proliferation.	  	  T3SS-­‐1	  mediates	  Salmonella	  invasion	  of	  epithelial	  cells	  and	  T3SS-­‐2	  is	  essential	  for	  macrophage	  survival	  [10,	  28].	  	  T6SS	  has	  also	  been	  indicated	  in	  bacterial	  infection,	  intracellular	  survival,	  biofilm	  formation,	  flagella	  regulation,	  quorum	  sensing,	  and	  stress	  response	  for	  Salmonella	  
enterica	  [21].	  	  S.	  Typhimurium	  and	  S.	  Typhi	  are	  capable	  of	  releasing	  proteins	  via	  T3SS	  that	  will	  provoke	  its	  own	  uptake	  into	  target	  host	  cells	  wherein	  it	  triggers	  a	  secondary	  T3SS	  that	  will	  release	  additional	  effectors	  in	  order	  to	  impair	  phagosome	  maturation,	  the	  generation	  of	  SCV,	  and	  prevent	  phagosome-­‐lysosome	  fusion	  [3,	  25].	  	  This	  type	  of	  bacterial	  internalization	  occurs	  when	  membrane	  ruffles	  are	  formed	  as	  a	  result	  of	  cytoskeletal	  rearrangements	  caused	  by	  T3SS	  effectors.	  	  T3SS-­‐2,	  located	  on	  SPI-­‐2,	  is	  capable	  of	  preventing	  fusion	  of	  NADPH-­‐dependent	  oxidase	  with	  SCV	  thereby	  inhibiting	  the	  production	  of	  reactive	  oxygen	  species	  (ROS)	  inside	  the	  vacuole.	  	  T3SSs	  are	  strongly	  conserved	  but	  the	  effector	  proteins	  released	  into	  host	  cytoplasm	  are	  highly	  variable,	  contributing	  to	  distinct	  virulence	  patterns	  [25].	  	  	  T3SSs	  are	  regulated	  through	  Salmonella	  pathogenicity	  islands	  (SPIs),	  specifically	  SPI-­‐1	  and	  SPI-­‐2	  regulate	  T3SS-­‐1	  and	  T3SS-­‐2	  respectively,	  which	  are	  clusters	  of	  virulence	  genes	  located	  either	  on	  the	  bacterial	  chromosome	  or	  embedded	  in	  virulence	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plasmids.	  	  To	  date,	  there	  have	  been	  12	  SPIs	  identified	  [18].	  	  SPIs	  are	  horizontally-­‐acquired	  genetic	  elements,	  whereby	  incorporation	  proceeds	  into	  non-­‐progeny.	  	  Examples	  of	  horizontal	  gene	  transfer	  are	  transformations	  (uptake	  and	  expression	  of	  foreign	  genetic	  material),	  transductions	  (transfer	  of	  bacterial	  DNA	  from	  one	  bacterium	  to	  another	  via	  bacteriophages),	  and	  bacterial	  conjugation	  (transfer	  of	  genetic	  material	  through	  bacterial	  cell-­‐to-­‐cell	  contact).	  	  Salmonella	  are	  not	  naturally	  transformable	  and	  typically	  undergo	  horizontal	  gene	  transfer	  through	  transductions	  and	  conjugation.	  	  	  SPI-­‐1	  is	  essential	  to	  the	  initiation	  of	  bacterial	  infection	  and	  invasion	  of	  the	  intestinal	  tract,	  while	  SPI-­‐2,	  which	  contains	  a	  second	  T3SS,	  is	  crucial	  for	  bacterial	  survival	  within	  host	  macrophages	  [13,	  18,	  36].	  	  A	  25	  kb	  fragment	  containing	  four	  operons	  (regulatory,	  structural	  I,	  structural	  II,	  and	  effector/chaperone)	  responds	  to	  SPI-­‐2	  T3SS	  [10].	  	  SPI-­‐2	  operons	  are	  transcriptionally	  regulated	  by	  a	  two-­‐component	  regulatory	  system,	  SsrA/SsrB	  [10].	  	  	  
Two-­Component	  Regulatory	  Systems	  Two-­‐component	  regulatory	  systems	  allow	  bacteria	  to	  interact	  with	  their	  environment	  by	  sensing	  and	  responding	  to	  changes	  in	  external	  conditions	  [35].	  	  Generally,	  two-­‐component	  regulatory	  systems	  consist	  of	  a	  histidine	  protein	  kinase	  (HK)	  and	  a	  response	  regulator	  (RR).	  	  Contents	  within	  the	  external	  environment	  are	  sensed	  by	  and	  thereby	  activate	  HK,	  which	  in	  turn,	  phosphorylates	  RR	  resulting	  in	  the	  activation	  of	  an	  effector	  domain	  that	  produces	  the	  desired	  response	  for	  the	  present	  environmental	  condition	  [35].	  	  The	  basic	  chemistry	  for	  a	  two-­‐component	  activation	  and	  deactivation	  can	  be	  better	  visualized	  in	  Table	  2.	  	  These	  systems	  allow	  bacteria	  to	  respond	  effectively	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to	  the	  harsh	  host	  environments,	  including	  nitrogen	  and	  phosphate	  limitation,	  sugar	  transport	  and	  osmolarity	  by	  regulating	  effector	  proteins.	  	  For	  example,	  PhoP	  and	  PhoQ	  proteins	  express	  genes	  (i.e.,	  phoP,	  phoQ,	  and	  pagC)	  required	  for	  bacterial	  virulence	  and	  intracellular	  survival	  [24].	  	  Mutant	  strains	  with	  defective	  phoP	  are	  less	  successful	  at	  surviving	  within	  macrophages	  and	  displayed	  increased	  sensitivity	  to	  small	  cationic	  peptides	  known	  as	  defensins	  [24].	  
Fimbriae	  Fimbriae	  are	  also	  significant	  elements	  for	  virulence	  through	  the	  initial	  bacterial	  invasion	  of	  the	  intestinal	  tract	  by	  mediating	  adhesion	  to	  the	  epithelial	  cells	  of	  the	  intestine	  [34].	  	  Specifically	  Salmonella	  fimbriae	  adhere	  the	  bacteria	  to	  the	  M-­‐cells	  of	  the	  intestine	  [4].	  	  There	  have	  been	  13	  predicted	  fimbrial	  loci	  determined	  for	  Salmonella	  species,	  one	  of	  which	  is	  FimH	  that	  has	  specifically	  been	  shown	  to	  assist	  in	  the	  uptake	  of	  bacteria	  into	  murine	  dendritic	  cells	  independent	  of	  secretion	  systems	  [15].	  	  These	  filamentous	  structures,	  also	  referred	  to	  as	  pili,	  are	  located	  on	  the	  outer	  membrane	  of	  
Salmonella	  and	  are	  typically	  2	  to	  8	  nm	  wide	  and	  0.5	  to	  10	  µm	  long	  [38].	  	  Their	  primary	  components	  are	  fimbrins	  that	  are	  helically	  arranged	  repeating	  proteins.	  	  	  
Flagella	  	   	  As	  a	  virulence	  factor,	  flagella	  is	  most	  important	  for	  the	  initial	  stages	  of	  pathogenicity	  through	  the	  facilitation	  of	  host	  cell	  invasion	  by	  allowing	  Salmonella	  to	  swim	  to	  target	  cells	  within	  the	  host.	  	  It	  is	  also	  considered	  to	  be	  essential	  for	  prolonging	  of	  the	  infection.	  	  Flagella	  are	  long	  helical	  filaments	  attached	  to	  rotary	  motors	  integrated	  into	  the	  bacterial	  membrane	  and	  are	  designed	  for	  swimming	  or	  swarming	  [30].	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Structurally,	  flagella	  require	  over	  50	  genes	  to	  synthesize	  the	  basal	  body,	  hook,	  and	  a	  filament,	  all	  of	  which	  make	  up	  its	  composition	  [37].	  	  The	  filament	  of	  flagella	  is	  comprised	  of	  a	  protein	  called	  flagellin	  and	  this	  protein	  often	  recognized	  by	  host	  immune	  system	  as	  pathogen-­‐associated	  molecular	  patterns	  (PAMPs)	  thereby	  activating	  the	  expression	  of	  proinflammatory	  cytokines	  [30,	  41].	  	  	  	  HOST	  SPECIFICITY	  	   Each	  host	  provides	  a	  unique	  environment	  of	  varying	  chemical	  and	  physical	  properties	  in	  which	  pathogens	  must	  persist	  by	  sustaining	  themselves	  throughout	  differing	  temperature,	  pH,	  osmolarity,	  and	  nutrient	  availability	  on	  top	  of	  evading	  host	  immune	  responses	  [25].	  	  Salmonella	  enterica	  serovars	  can	  be	  identified	  as	  generalists,	  host-­‐restricted,	  or	  host-­‐specific.	  	  S.	  Typhimurium	  and	  S.	  Enteriditis	  are	  considered	  generalists	  because	  they	  have	  a	  broad	  range	  of	  hosts	  they	  can	  infect	  but	  the	  effects	  of	  infection	  vary	  from	  host	  to	  host.	  	  	  Although	  host-­‐restricted	  species,	  such	  as	  S.	  Dublin,	  typically	  perpetuate	  disease	  in	  one	  particular	  host,	  it	  is	  capable	  of	  causing	  disease	  in	  other	  animals	  under	  certain	  circumstances.	  	  On	  the	  other	  hand,	  host-­‐specific	  strains	  can	  only	  induce	  disease	  in	  one	  specific	  host.	  	  An	  example	  of	  this	  is	  S.	  Typhi	  because	  it	  only	  causes	  typhoid	  fever	  in	  humans.	  	  Host-­‐restricted	  and	  host-­‐specific	  strains	  are	  often	  associated	  with	  systemic	  infection	  in	  a	  particular	  host	  [27].	  	  As	  stated,	  the	  pathogenicity	  of	  each	  strain	  can	  vary	  with	  their	  degree	  of	  host	  specificity.	  	  Paulin	  and	  colleagues	  (2002)	  determined	  that	  Salmonella	  colonization	  of	  calf	  intestines	  is	  affected	  by	  two	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elements:	  (1)	  initial	  intestinal	  invasion	  and	  (2)	  subsequent	  bacterial	  persistence	  and	  growth,	  both	  of	  which	  are	  highly	  contingent	  on	  the	  degree	  of	  host	  specificity.	  	  	  	  	  The	  initial	  surface	  contact	  between	  Salmonella	  and	  the	  host	  is	  the	  intestinal	  mucosa	  of	  the	  gut.	  	  This	  interaction	  can	  be	  delineated	  into	  three	  stages:	  (1)	  arrival	  and	  contact	  with	  intestinal	  mucosa,	  (2)	  penetration	  of	  or	  trapping	  by	  the	  mucus	  gel	  and	  (3)	  adhesion	  to	  epithelial	  cells	  [11].	  	  The	  ability	  to	  bind	  to	  and	  colonize	  the	  intestinal	  mucosa	  along	  with	  other	  surfaces	  of	  target	  cells	  is	  essential	  to	  determining	  the	  host	  specificity	  of	  the	  strain.	  	  Not	  only	  is	  host	  specificity	  derived	  from	  the	  pathogen’s	  ability	  to	  adhere	  to	  the	  target	  surfaces	  but	  surviving	  within	  host	  macrophages	  while	  counterbalancing	  host	  responses	  can	  determine	  whether	  the	  bacterium	  is	  a	  generalist,	  host-­‐restricted,	  or	  host-­‐specific.	  	  	   	  
Host	  Response	  	   The	  immune	  system	  of	  the	  host	  is	  made	  up	  of	  multiple	  cell	  types	  that	  may	  contribute	  to	  the	  nuances	  of	  host	  specificity.	  	  For	  example,	  the	  immune	  system	  is	  equipped	  to	  detect	  LPS	  and	  lipoproteins	  of	  gram-­‐negative	  bacteria.	  	  Once	  the	  pathogens	  are	  recognized,	  host	  immune	  factors	  typically	  function	  to	  successfully	  abolish	  bacterial	  infection.	  	  However,	  during	  instances	  where	  the	  pathogen	  is	  better	  equipped	  to	  survive,	  the	  immune	  system	  is	  still	  able	  to	  recognize	  the	  presence	  of	  pathogens	  thereby	  producing	  immune	  responses	  that	  show	  signs	  of	  the	  disease	  persisting.	  	  Host	  environment	  also	  contains	  antimicrobial	  peptides	  that	  are	  small,	  amphipathic	  molecules	  located	  on	  the	  epithelial	  surfaces	  inside	  phagocytes,	  which	  also	  colocalizes	  with	  NADPH-­‐dependent	  oxidase	  that	  catalyzes	  the	  production	  of	  ROS	  [25].	  	  Not	  only	  is	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the	  host	  capable	  of	  producing	  ROS	  but	  also	  hinders	  foreign	  invasion	  through	  the	  presence	  of	  nitric	  oxide	  and	  other	  reactive	  nitrogen	  compounds	  that	  can	  be	  found	  within	  macrophages.	  	  Salmonella	  can	  combat	  these	  macrophage	  effects	  through	  the	  production	  of	  enzymes	  like	  superoxide	  dismutase.	  
Macrophage	  survival	  	   Macrophages	  are	  phagocytic	  monocytes	  that	  can	  be	  found	  in	  almost	  all	  tissue	  types	  and	  are	  responsible	  for	  tissue	  homeostasis	  and	  immune	  response	  [22].	  	  	  There	  have	  been	  conflicting	  views	  on	  the	  role	  of	  macrophages	  on	  host	  specificity	  due	  to	  discrepancies	  between	  in	  vivo	  and	  in	  vitro	  assays,	  which	  may	  be	  explained	  by	  the	  increased	  expression	  of	  cytokine	  factors.	  	  A	  study	  conducted	  by	  Xu	  and	  colleagues	  (2009)	  demonstrated	  that	  there	  was	  an	  increased	  expression	  of	  IL-­‐6,	  IL-­‐1α,	  and	  TNFα	  during	  S.	  Typhimurium	  infection	  when	  compared	  to	  S.	  Typhi	  infection	  both	  of	  which	  also	  differ	  on	  uptake	  into	  macrophages,	  whereby	  S.	  Typhi	  is	  identified	  and	  cleared	  more	  quickly.	  	  Regardless	  of	  the	  controversy,	  surviving	  within	  macrophages	  is	  essential	  to	  
Salmonella	  pathogenicity.	  	  There	  are	  two	  systems	  that	  play	  a	  role	  in	  macrophage	  survival:	  (1)	  PhoPQ,	  a	  two-­‐component	  regulatory	  system	  and	  (2)	  SPI-­‐2	  T3SS	  [10].	  Once	  the	  pathogen	  is	  ingested	  by	  the	  macrophage,	  the	  formation	  of	  a	  spacious	  phagosome	  that	  develops	  into	  SCV	  occurs	  as	  the	  macrophage	  begins	  to	  fuse	  with	  a	  lysosome.	  	  The	  lysosome	  then	  serves	  to	  break	  down	  the	  pathogen	  with	  acid	  hydrolases	  [6].	  	  Recent	  studies	  have	  demonstrated	  that	  Salmonella	  will	  often	  multiply	  and	  divide	  within	  the	  SCV,	  which	  in	  turn	  divides	  the	  SCV	  resulting	  in	  one	  vacuole	  typically	  containing	  only	  one	  bacterium	  [6,	  18].	  	  Eswarrappa	  and	  colleagues	  (2010)	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demonstrated	  that	  lysosomes	  are	  not	  produced	  in	  conjunction	  with	  the	  increasing	  SCVs	  but	  instead	  are	  actively	  reduced	  in	  number.	  	  	  SCV	  division	  causes	  a	  redistribution	  of	  components	  required	  for	  lysosomal	  biogenesis,	  such	  as	  vacuolar-­‐type	  ATPase,	  LAMP1,	  LAMP2,	  cathepsin	  D,	  and	  acid	  phosphatase	  [6,	  18].	  	  Figure	  2	  depicts	  a	  probable	  hypothesis	  of	  how	  this	  may	  occur.	  	  The	  limited	  lysosomes	  will	  target	  SCVs	  containing	  clusters	  of	  bacteria;	  therefore,	  the	  number	  of	  bacteria	  found	  within	  each	  SCV	  plays	  a	  role	  in	  Salmonella	  host	  survival	  and	  cell	  proliferation.	  	  	  Not	  only	  must	  the	  strain	  thwart	  lysosomal	  effects	  but	  it	  must	  also	  withstand	  ROS,	  reactive	  nitrogen	  species,	  antimicrobial	  peptides	  and	  adaptive	  host	  immune	  responses	  [12].	  	  Effector	  proteins	  released	  from	  SPI-­‐2	  T3SS	  combat	  these	  effects.	  	  SPI-­‐2	  virulence	  genes	  are	  required	  for	  macrophage	  survival,	  intracellular	  proliferation	  and	  systemic	  infection	  [12].	  	  Many	  of	  these	  virulence	  genes	  are	  regulated	  by	  two-­‐component	  systems,	  such	  as	  SpiR/SsrB	  that	  can	  be	  found	  encoded	  into	  the	  SPI-­‐2	  pathogenicity	  island	  [8].	  	  SsrB	  protein	  is	  required	  for	  the	  expression	  of	  SPI-­‐2	  T3SS	  and	  its	  effectors	  [8].	  	  As	  stated	  previously,	  the	  PhoP/PhoQ	  two-­‐component	  system	  is	  also	  essential	  for	  macrophage	  intracellular	  survival	  as	  demonstrated	  through	  the	  inability	  of	  mutant	  strains	  to	  proliferate.	  	  PhoP	  triggers	  the	  induction	  of	  SPI-­‐2	  in	  the	  presence	  of	  low	  magnesium	  levels	  and	  low	  pH	  such	  as	  that	  which	  can	  be	  found	  within	  macrophages	  [8].	  	  	  	  	  	  NEUROPATHOGENIC	  STRAIN	  OF	  SSTP	  In	  2002,	  a	  neuropathogenic	  strain	  of	  Sstp,	  which	  will	  be	  referred	  as	  SstpNPG	  from	  hereon,	  was	  first	  isolated	  from	  a	  4-­‐month	  old	  Holstein	  calf	  in	  Wisconsin	  that	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displayed	  signs	  of	  diarrhea,	  head	  tilt,	  ataxia,	  auditory	  hyper-­‐responsiveness,	  and	  partial	  blindness	  [23].	  	  Field	  observations	  revealed	  a	  moderate	  morbidity	  rate	  of	  40%	  on	  calves	  but	  a	  low	  mortality	  rate	  (0%).	  	  McCuddin	  and	  colleagues	  (2008)	  determined	  that	  the	  strain	  has	  a	  low	  infection	  rate	  due	  to	  SstpNPG	  being	  recovered	  only	  from	  1	  of	  12	  calves.	  	  	  Standard	  hematoxylin	  and	  eosin	  (H	  &	  E)	  histopathology	  of	  the	  brain	  showed	  no	  significant	  signs	  of	  disease	  or	  inflammation	  and	  only	  one	  CFU	  from	  each	  10	  g	  of	  brain	  tissue	  was	  observed	  [23].	  	  	  	  PURPOSE	  	   NTS	  encephalopathy	  is	  a	  rare	  occurrence	  due	  to	  the	  fact	  that	  systemic	  infection	  is	  not	  as	  common	  among	  these	  strains	  and	  even	  fewer	  bacterial	  pathogens	  are	  capable	  of	  crossing	  the	  BBB.	  	  Interestingly,	  SstpNPG	  is	  capable	  of	  inducing	  encephalopathy	  in	  stressed	  calves.	  	  Calves	  infected	  by	  SstpNPG	  and	  stressed	  from	  transportation	  and/or	  co-­‐mingling	  often	  show	  signs	  of	  ear	  fluttering	  and	  seizures.	  	  This	  alludes	  to	  a	  relationship	  between	  host	  neuroendocrine	  hormones	  and	  the	  traversal	  of	  the	  BBB.	  	  Once	  inside	  the	  brain,	  little	  is	  known	  on	  the	  mechanism	  of	  infection	  that	  would	  produce	  these	  signs	  of	  neurological	  deficiencies.	  	  A	  better	  understanding	  of	  this	  may	  lead	  to	  pharmacological	  developments	  and/or	  ways	  to	  abrogate	  the	  disease.	  	  In	  order	  to	  gain	  knowledge	  on	  SstpNPG	  and	  its	  relationship	  with	  calves	  the	  following	  were	  ascertained:	  (1)	  host	  condition	  specificity	  of	  the	  strain	  (2)	  genes	  involved	  in	  the	  traversal	  of	  BBB	  and	  the	  relationship	  it	  has	  with	  neuroendocrine	  hormones,	  (3)	  abrogation	  of	  symptoms	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through	  antibiotics,	  and	  (4)	  identification	  of	  factors	  involved	  in	  perpetuating	  encephalopathy.	  	  	  REFERENCES	  	  1.	  	  	   Bell	  RL,	  González-­‐Escalona	  N,	  Stones	  R,	  and	  Brown	  EW.	  2011.	  Phylogenetic	  evaluation	  of	  the	  ‘Typhimurium’	  complex	  of	  Salmonella	  strains	  using	  a	  seven-­‐gene	  multi-­‐locus	  sequence	  analysis.	  Infection,	  Genetics,	  and	  Evolution,	  11(1):	  83-­‐91.	  	  DOI:10.1016/j.meegid.2010.10.005.	  	  	  	  2.	  	  	   Beyer	  W,	  Mukendi	  FM,	  Kimmig	  P,	  and	  Böhm	  R.	  1998.	  Suitability	  of	  repetitive-­‐DNA-­‐sequence-­‐based	  PCR	  fingerprinting	  for	  characterizing	  epidemic	  isolates	  of	  
Salmonella	  enterica	  serovar	  Saintpaul.	  Journal	  of	  Clinical	  Microbiology,	  36(6):	  1549-­‐1554.	  	  3.	  	  	   Bischofberger	  M	  and	  van	  der	  Goot	  FG.	  2008.	  Exotoxin	  secretion:	  getting	  out	  to	  find	  the	  way	  in.	  Cell	  Host	  &	  Microbe	  Previews,	  3:	  7-­‐8.	  DOI:10.1016/j.chom.2007.12.003.	  	  4.	  	  	   Edwards	  RA,	  Schifferli	  DM,	  and	  Maloy	  SR.	  2000.	  A	  role	  for	  Salmonella	  fimbriae	  in	  intraperitoneal	  infections.	  Proceedings	  of	  the	  National	  Academy	  of	  Sciences,	  97(3):	  1258-­‐1262.	  	  	  	  5.	  	  	   Ernst	  RK,	  Guina	  T,	  and	  Miller	  SI.	  1999.	  How	  intracellular	  bacteria	  survive:	  surface	  modifications	  that	  promote	  resistance	  to	  host	  innate	  immune	  responses.	  
Journal	  of	  Infectious	  Diseases,	  179(Suppl	  2):	  S326-­‐30.	  DOI:	  10.1086/513850.	  	  6.	  	  	   Eswarappa	  SM,	  Negi	  VD,	  Chakraborty	  S,	  Sagar	  BKC,	  and	  Chakravortty	  D.	  2010.	  Division	  of	  the	  Salmonella-­‐containing	  vacuole	  and	  depletion	  of	  acidic	  lysosomes	  in	  Salmonella-­‐infected	  host	  cells	  are	  novel	  strategies	  of	  Salmonella	  enterica	  to	  avoid	  lysosomes.	  Infection	  and	  Immunity,	  78(1):	  68-­‐79.	  DOI:10.1128/IAI.00668-­‐09.	  	  7.	  	  	   Eswarappa	  SM,	  Janice	  J,	  Nagarajan	  AG,	  Balasundaram	  SV,	  Karnam	  G,	  Dixit	  NM,	  and	  Chakravortty	  D.	  2008.	  Differentially	  evolved	  genes	  of	  Salmonella	  pathogenecity	  islands:	  insights	  into	  the	  mechanism	  of	  host	  specificity	  in	  
Salmonella.	  Public	  Library	  of	  Science	  One,	  3(12):	  e3829.	  DOI:10.1371/journal.pone.0003829.	  	  
	   18	  
8.	  	  	   Fass	  E	  and	  Groisman	  EA.	  2009.	  Control	  of	  Salmonella	  pathogenicity	  island-­‐2	  gene	  expression.	  Current	  Opinions	  of	  Microbiology,	  12(2):	  199-­‐204.	  DOI:10.1016/j.mib.2009.01.004.	  	  9.	  	  	   Foley	  SL	  and	  Lynne	  AM.	  2008.	  Food	  animal-­‐associated	  Salmonella	  challenges:	  Pathogenicity	  and	  antimicrobial	  resistance.	  Journal	  of	  Animal	  Science,	  86:	  E173-­‐E187.	  DOI:	  10.2527/jas.2007-­‐0447.	  	  10.	  	   Forest	  CG,	  Ferraro	  E,	  Sabbagh	  SC,	  and	  Daigle	  F.	  2010.	  Intracellular	  survival	  of	  
Salmonella	  enterica	  serovar	  Typhi	  in	  human	  macrophages	  is	  independent	  of	  
Salmonella	  pathogenicity	  island	  (SPI)-­‐2.	  Microbiology,	  156:	  3689-­‐3698.	  DOI:10.1099/mic.0.041624-­‐0.	  	  11.	  	  	   Frost	  AJ,	  Bland	  AP,	  and	  Wallis	  TS.	  1997.	  The	  early	  dynamic	  response	  of	  the	  calf	  ileal	  epithelium	  to	  Salmonella	  typhimurium.	  Veterinary	  Pathology,	  34:	  369-­‐386.	  DOI:10.1177/030098589703400501.	  	  12.	  	  	   Ge	  S,	  Danino	  V,	  He	  Q,	  Hinton	  JCD,	  and	  Granfors	  K.	  2010.	  Microarray	  analysis	  of	  response	  of	  Salmonella	  during	  infection	  of	  HLA-­‐B27-­‐	  transfected	  human	  macrophage-­‐like	  U937	  cells.	  BioMed	  Central	  Genomics,	  11:	  456-­‐459.	  DOI:10.1186/1471-­‐2164-­‐11-­‐456.	  	  13.	  	  	   Hansen-­‐Wester	  I	  and	  Hensel	  M.	  2001.	  Salmonella	  pathogenicity	  islands	  encoding	  type	  III	  secretion	  systems.	  Microbes	  and	  Infection,	  3:	  549-­‐559.	  DOI:10.1016/S1286-­‐4579(01)01411-­‐3.	  	  	  14.	  	  	   Huehn	  S	  and	  Malorny	  B.	  Caugant	  DA	  (ed).	  2009.	  Chapter	  19:	  DNA	  microarray	  for	  molecular	  epidemiology	  of	  Salmonella.	  Molecular	  Epidemiology	  of	  
Microorganisms,	  Methods	  in	  Molecular	  Biology,	  551:	  249-­‐285.	  DOI:	  10.1007/978-­‐1-­‐60327-­‐999-­‐4_19.	  	  15.	  	  	   Ibarra	  JA	  and	  Steele-­‐Mortimer	  O.	  2009.	  Salmonella	  –	  the	  ultimate	  insider.	  	  
Salmonella	  virulence	  factors	  that	  modulate	  intracellular	  survival.	  Cellular	  
Microbiology,	  11(11):	  1579-­‐1586.	  DOI:10.1111/j.1462-­‐5822.2009.01368.	  	  16.	  	  	   Khan	  SA,	  Everest	  P,	  Servos	  S,	  Foxwell	  N,	  Zähringer	  U,	  Brade	  H,	  Rietschel	  ETh,	  Dougan	  G,	  Charles	  IG,	  and	  Maskell	  DJ.	  1998.	  A	  lethal	  role	  for	  lipid	  A	  in	  Salmonella	  infections.	  Molecular	  Microbiology,	  29(2):	  571-­‐579.	  DOI:	  10.1046/j.1365-­‐2958.1998.00952.x.	  	  	  17.	  	  	   Kraehenbuhl	  J-­‐P	  and	  Neutra	  MR.	  2000.	  Epithelial	  M	  cells:	  differentiation	  and	  function.	  Annual	  Review	  of	  Cell	  and	  Developmental	  Biology,	  16:	  301-­‐332.	  DOI:10.1146/annurev.cellbio.16.1.301.	  	  
	   19	  
18.	  	  	   Lahiri	  A,	  Lahiri	  A,	  Iyer	  N,	  Das	  P,	  and	  Chakravortty	  D.	  2010.	  Visiting	  the	  cell	  biology	  of	  Salmonella	  infection.	  Microbes	  and	  Infection,	  12(11):	  809-­‐818.	  DOI:10.1016/j.micinf.2010.05.010.	  	  19.	  	  	   Liao	  C-­‐H,	  Cooke	  PH,	  and	  Niemira	  BA.	  2010.	  Localization,	  growth,	  and	  inactivation	  of	  Salmonella	  Saintpaul	  on	  jalapeño	  peppers.	  Journal	  of	  Food	  Science,	  75(6):	  M377-­‐M382.	  DOI:	  10.1111/j.1750-­‐3841.2010.01667.x.	  	  	  20.	  	  	   Libby	  SJ,	  Adams	  LG,	  Ficht	  TA,	  Allen	  C,	  Whitford	  HA,	  Buchmeier	  NA,	  Bossie	  S,	  and	  Guiney	  DG.	  1997.	  The	  spv	  genes	  on	  the	  Salmonella	  dublin	  virulence	  plasmid	  are	  required	  for	  severe	  enteritis	  and	  systemic	  infection	  in	  the	  natural	  host.	  Infection	  
and	  Immunity,	  65:	  1786-­‐1792.	  	  	  	  21.	  	   Leung	  KY,	  Siame	  BA,	  Snowball	  H	  and	  Mok	  Y.	  2010.	  Type	  IV	  secretion	  regulation:	  crosstalk	  and	  intracellular	  communication.	  Current	  Opinion	  in	  Microbiology,	  14:	  1-­‐7.	  	  DOI	  10.1016/j.mib.2010.09.017.	  	  22.	  	  	   Lucas	  AD	  and	  Greaves	  DR.	  2001.	  Atherosclerosis:	  role	  of	  chemokines	  and	  macrophages.	  Expert	  Review	  of	  Molecular	  Medicine,	  3(25):	  1-­‐18.	  	  DOI:10.1017/S1462399401003696.	  	  	  	  23.	  	  	   McCuddin	  ZP,	  Carlson	  SA,	  and	  Sharma	  VK.	  2008.	  Experimental	  reproduction	  of	  bovine	  Salmonella	  encephalopathy	  using	  a	  norepinephrine-­‐based	  stress	  model.	  	  
The	  Veterinary	  Journal,	  175:	  82-­‐88.	  	  DOI:10.1016/j.tvjl.2006.12.014.	  DOI:10.1016/j.tvjl.2006.12.014.	  	  24.	  	  	   Miller	  SI,	  Kukral	  AM,	  and	  Mekalanos	  JJ.	  1989.	  A	  two-­‐component	  regulatory	  system	  (phoP	  phoQ)	  controls	  Salmonella	  typhimurium	  virulence.	  Proceedings	  of	  
the	  National	  Academy	  of	  Sciences,	  86:	  5054-­‐5058.	  	  	  	  25.	  	   	  Ohl	  ME	  and	  Miller	  SI.	  2001.	  Salmonella:	  a	  model	  for	  bacterial	  pathogenesis.	  	  
Annual	  review	  of	  Medicine,	  52:	  259-­‐274.	  DOI:	  10.1146/annurev.med.52.1.259.	  	  26.	  	  	   Paulin	  SM,	  Watson	  PR,	  Benmore	  AR,	  Stevens	  MP,	  Jones	  PW,	  Villarreal-­‐Ramos	  B,	  and	  Wallis	  TS.	  2002.	  Analysis	  of	  Salmonella	  enterica	  serotype-­‐host	  specificity	  in	  calves:	  avirulence	  of	  S.	  enterica	  serotype	  Gallinarum	  correlates	  with	  bacterial	  dissemination	  from	  mesenteric	  lymph	  nodes	  and	  persistence	  in	  vivo.	  Infection	  
and	  Immunity,	  70(12):	  6788-­‐6797.	  DOI:	  10.1128/IAI.70.12.6788–6797.2002.	  	  27.	  	  	   Pullinger	  GD,	  van	  Diemen	  PM,	  Dziva	  F,	  and	  Stevens	  MP.	  2010.	  Role	  of	  two-­‐component	  sensory	  systems	  of	  Salmonella	  enterica	  serovar	  Dublin	  in	  pathogenesis	  of	  systemic	  salmonellosis	  in	  cattle.	  Microbiology,	  156:	  3108-­‐3122.	  DOI:10.1099/mic.0.041830-­‐0.	  	  
	   20	  
28.	  	  	   Raffatellu	  M,	  Wilson	  RP,	  Winter	  SE,	  Bäumler	  AJ.	  2008.	  Clinical	  pathogenesis	  of	  typhoid	  fever.	  Journal	  of	  Infection	  in	  Developing	  Countries,	  2(4):	  260-­‐266.	  	  29.	  	  	   Rotger	  R	  and	  Casadesus	  J,	  1999.	  The	  virulence	  plasmids	  of	  Salmonella.	  
International	  Microbiology,	  2:	  177-­‐184.	  	  	  	  30.	  	  	   Saini	  S,	  Slauch	  JM,	  Aldridge	  PD,	  and	  Rao	  CV.	  2010.	  Role	  of	  cross	  talk	  in	  regulating	  the	  dynamic	  expression	  of	  the	  flagellar	  Salmonella	  pathogenicity	  island	  1	  and	  type	  1	  fimbrial	  genes.	  Journal	  of	  Bacteriology,	  192(21):	  5767-­‐5777.	  	  DOI:10.1128/JB.00624-­‐10.	  	  31.	  	  	   Santos	  RL,	  Zhang	  S,	  Tsolis	  RM,	  Bäumler	  AJ,	  and	  Adams	  LG.	  2002.	  Morphologic	  and	  molecular	  characterization	  of	  Salmonella	  typhimurium	  infection	  in	  neonatal	  calves.	  Veterinary	  Pathology,	  39:	  200-­‐215.	  DOI:	  10.1354/vp.39-­‐2-­‐200.	  	  	  32.	  	  	   Santos	  RL,	  Zhang	  S,	  Tsolis	  RM,	  Kingsley	  RA,	  Adams	  LG,	  and	  Bäumler	  AJ.	  2001.	  Animal	  models	  of	  Salmonella	  infections:	  enteritis	  versus	  typhoid	  fever.	  Microbes	  
and	  Infection,	  3:	  1355-­‐1344.	  DOI:10.1016/S1286-­‐4579(01)01495-­‐2.	  	  33.	  	  	   Spanò	  S,	  Ugalde	  JE,	  and	  Galán	  JE.	  2008.	  Delivery	  of	  Salmonella	  Typhi	  exotoxin	  from	  a	  host	  intracellular	  compartment.	  Cell	  Host	  &	  Microbe,	  3:	  30-­‐38.	  DOI:10.1016/j.chom.2007.11.001.	  	  34.	  	  	   Stevens	  MP,	  Humphrey	  TJ,	  and	  Maskell	  DJ.	  2009.	  Molecular	  insights	  into	  farm	  animal	  and	  zoonotic	  Salmonella	  infections.	  Philosophical	  Transactions	  of	  the	  
Royal	  Society,	  364:	  2709-­‐2723.	  DOI:10.1098/rstb.2009.0094.	  	  35.	  	  	   Stock	  AM,	  Robinson	  VL,	  and	  Goudreau	  PN.	  2000.	  Two-­‐component	  signal	  transduction.	  Annual	  Review	  of	  Biochemistry,	  69:	  183-­‐215.	  DOI:10.1146/annurev.biochem.69.1.183	  	  36.	  	  	   Suárez	  M	  and	  Rüssmann	  H.	  1998.	  Molecular	  mechanisms	  of	  Salmonella	  invasion:	  the	  type	  III	  secretion	  system	  of	  the	  pathogenicity	  island	  1.	  International	  
Microbiology,	  1:	  197-­‐204.	  	  	  	  37.	  	  	   Uchiya	  K,	  Sugita	  A,	  and	  Nikai	  T.	  2009.	  Involvement	  of	  SPI-­‐2-­‐encoded	  SpiC	  in	  flagellum	  synthesis	  in	  Salmonella	  enterica	  serovar	  Typhimuirum.	  BioMed	  Central	  
Microbiology,	  9:	  179.	  DOI:10.1186/1471-­‐2180-­‐9-­‐179.	  	  38.	  	  	   van	  Asten	  AJAM	  and	  van	  Dijk	  JE.	  2005.	  Distribution	  of	  “classic”	  virulence	  factors	  among	  Salmonella	  spp.	  FEMS	  Immunology	  and	  Medical	  Microbiology,	  44:	  251-­‐259.	  	  DOI:10.1016/j.femsim.2005.02.002.	  	  
	   21	  
39.	  	  	   Xi	  M,	  Zheng	  J,	  Zhao	  S,	  Brown	  EW	  and	  Meng	  J.	  2008.	  An	  enhanced	  discriminatory	  pulsed-­‐field	  gel	  electrophoresis	  scheme	  for	  subtyping	  Salmonella	  serotypes	  Heidelberg,	  Kentucky,	  SaintPaul,	  and	  Hadar.	  Journal	  of	  Food	  Protection,	  71(10):	  2067-­‐2072.	  	  40.	  	  	   Xu	  T,	  Maloy	  S,	  and	  McGuire	  KL.	  2009.	  Macrophage	  influence	  Salmonella	  host-­‐specificity	  in	  vivo.	  Microbial	  Pathogenesis,	  47:	  212-­‐222.	  DOI:10.1016/j.micpath.2009.07.004.	  	  41.	  	  	   Zipfel	  C,	  Robatzek	  S,	  Navarrow	  L,	  Oakeley	  EJ,	  Jones	  JDG,	  Felix	  G,	  and	  Boller	  T.	  	  2004.	  Bacterial	  disease	  resistance	  in	  Arabidopsis	  through	  flagellin	  perception.	  
Nature,	  428:	  764-­‐767.	  DOI:10.1038/nature02485.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	   22	  
Table	  1.	  	  Comparison	  between	  bacterial	  endotoxins	  and	  exotoxins	  	   PROPERTY	   ENDOTOXIN	   EXOTOXIN	  Molecular	  component	   Lipopolysaccharide	   Protein	  Location	   Outer	  membrane	   Diffusible	  element	  Potency	   Low	  (>	  100µg)	   High	  (1	  µg)	  Specificity	   Low	   High	  Enzymatic	  activity	   No	   Yes	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Table	  2.	  	  Basic	  chemistry	  of	  a	  two-­‐component	  phosphoryl	  transfer	  signal	  transduction	  pathway	  (as	  seen	  in	  Stock	  et	  al.	  	  2000)	  	  	  TYPE	  OF	  PHOSPHORYL	  TRANSFER	   SIGNAL	  TRANSDUCTION	  PATHWAY	  Autophosphorylation	   HK-­‐His	  +	  ATP	  ⇔	  HK-­‐His∼P	  +	  ADP	  Phosphotransfer	   HK-­‐His∼P	  +	  RR-­‐Asp	  ⇔	  HK-­‐His	  +	  RR-­‐Asp∼P	  Dephosphorylation	   RR-­‐Asp∼P	  +	  H2O	  ⇔	  RR-­‐Asp	  +	  Pi	  	  Autophosphorylation	  occurs	  on	  the	  histidine	  side	  chain	  of	  the	  HK,	  indicated	  by	  HK-­‐His.	  	  HK	  then	  transfers	  the	  phosphoryl	  group,	  ∼P,	  to	  the	  aspartate	  side	  chain	  of	  RR,	  designated	  with	  RR-­‐Asp.	  	  Dephosphorylation	  of	  RR	  occurs	  when	  the	  phosphoryl	  group	  is	  transferred	  to	  water,	  H2O.	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Figure	  1.	  	  S.	  	  Typhimurium	  gaining	  entrance	  into	  a	  Hep-­‐2	  cell	  via	  modification	  of	  host	  actin	  cytoskeleton	  and	  perpetuation	  of	  macropinocytosis	  mediated	  through	  membrane	  ruffles	  (as	  seen	  in	  Ohl	  and	  Miller	  2001).	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Figure 1 Scanning electron micrograph showing Salmonella typhimurium entering a
Hep-2 cell through bacterial mediated endocytosis. Membrane ruffles extend from the cell
surface, enclosing and internalizing adherent bacteria. (Electron micrograph in collabora-
tion with Dr. Carol Wells, University of Minnesota.)
appears important in recruiting neutrophils to the submucosal space, and factors
not yet defined promote transmigration of neutrophils across the epithelial barrier.
Once across the intestinal epithelium, salmonellae encounter another obstacle
of innate immunity, the submucosal macrophage. Salmonella serotypes that cause
systemic infection enter macrophages, again apparently by induced macropinocy-
tosis, and subsequently activate virulence mechanisms that allow evasion of the



















































	   25	  
Figure	  2.	  	  Possible	  trafficking	  of	  lysosomes	  to	  SCV	  (as	  seen	  in	  Lahiri	  et	  al.	  	  2010)	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important to study the mechanism by how 
this can be halted by a pathogen. There 
is a pressing need to design new drug to 
combat multidrug resistant Salmonella 
infection. For this purpose, novel bacte-
rial virulence factors and survival mecha-
nisms need to be identified. Hence, future 
studies should focus on looking further 
into the process of lysosome biogenesis 
under infection conditions with various 
other pathogens also. Identifying all of the 
virulence factors and signaling pathways 
involved in regulating SCV biogenesis 
might lead to newer therapeutic targets for 
novel drug design.
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remains to be answered is whether it is the 
total number of the acidic lysosomes which 
are decreasing or just the pH of the lyso-
somes are altered and hence the pH tracer 
used in our study can no longer detect the 
lysosomes. This can be answered by tag-
ging the lysosomes with LAMP-1 antibody 
and measuring the pH in those lysosomes 
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non-infected conditions which we could 
not perform in our work.
Summary
Successful pathogens can avoid the fusion 
with lysosomes, modulate their vacuole to 
stay in the lysosomes or can decrease the 
number of lysosomes. Lysosome biogen-
esis is a very dynamic process and it is very 
Figure 2. Di!erential tra"cking of Integral lysosomal membrane proteins to SCV: a probable hypothesis.
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CHAPTER	  2.	  	  EVALUATION	  OF	  THE	  PATHOGENICITY	  AND	  VIRULENCE	  
OF	  THREE	  STRAINS	  OF	  SALMONELLA	  ORGANISMS	  IN	  CALVES	  AND	  
PIGS	  	  Modification	  of	  a	  paper	  published	  in	  	  
American	  Journal	  of	  Veterinary	  Research	  
	  Nalee	  Xiong,	  Matt	  T	  Brewer,	  Tim	  A	  Day,	  Michael	  J	  Kimber,	  	  Alison	  E	  Barnhill,	  and	  Steve	  A	  Carlson	  	  	  ABSTRACT	  
	   The	  objective	  of	  this	  study	  was	  to	  assess	  in	  pigs	  the	  pathogenicity	  and	  virulence	  of	  Salmonella	  enterica	  serovar	  Saintpaul,	  which	  is	  capable	  of	  causing	  nontyphoidal	  
Salmonella	  encephalopathy	  (NTSE)	  in	  cattle.	  	  By	  experimentally	  infecting	  Holstein	  calves	  and	  pigs,	  clinical	  manifestations	  of	  pigs	  were	  compared	  with	  those	  observed	  in	  cattle.	  	  Salmonella-­‐mediated	  encephalopathy	  and	  multisystemic	  cytopathicity	  did	  not	  appear	  to	  be	  a	  relevant	  disease	  in	  swine.	  	  INTRODUCTION	  	   During	  the	  past	  10	  years,	  a	  unique	  type	  of	  salmonellosis	  in	  cattle	  has	  been	  identified	  and	  characterized	  by	  our	  laboratory	  group.	  	  This	  pathotype	  involved	  3	  strains	  of	  Salmonella	  capable	  of	  causing	  neurologic	  disease	  in	  cattle	  recently	  exposed	  to	  stressful	  situations	  such	  as	  transportation	  or	  co-­‐mingling.	  	  These	  strains	  included	  S.	  
enterica	  serotypes	  Saintpaul,	  Montevideo,	  and	  Enteriditis	  isolated	  from	  calves	  in	  Minnesota	  and	  Wisconsin	  [4].	  	  Affected	  calves	  had	  signs	  of	  moderate	  to	  severe	  signs	  of	  neurologic	  disease	  ranging	  from	  excessive	  ear	  fluttering	  to	  seizures,	  and	  some	  calves	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had	  permanent	  neurologic	  deficits.	  	  The	  neurologic	  effects	  of	  these	  strains	  were	  reproduced	  in	  a	  laboratory	  setting	  using	  a	  norepinephrine-­‐based	  stress-­‐induction	  technique	  [4].	  	  These	  outbreaks	  of	  Salmonella	  encephalopathy	  are	  now	  extremely	  rare,	  but	  the	  potential	  for	  zoonotic	  transmission	  and	  the	  dramatic	  nature	  of	  the	  disease	  warrant	  further	  investigation	  in	  other	  food-­‐producing	  animals.	  	   Because	  of	  anecdotal	  reports	  suggesting	  unusual	  aspects	  of	  extraintestinal	  salmonellosis	  in	  pigs,	  the	  study	  reported	  here	  also	  investigated	  the	  potential	  for	  
Salmonella-­‐	  associated	  neuropathogenicity	  in	  pigs.	  	  For	  this	  neuropathogenicity	  study,	  subjects	  were	  inoculated	  with	  neuropathogenic	  Salmonella	  Saintpaul	  (SstpNPG)	  and	  then	  monitored	  for	  stress-­‐mediated	  neurologic	  disease	  and	  evidence	  of	  Salmonella	  organisms	  in	  various	  tissues.	  	  MATERIALS	  AND	  METHODS	  
Animals,	  bacterial	  strain	  and	  preparation	  	   The	  in	  vivo	  experiment	  involved	  the	  use	  of	  1-­‐to	  2-­‐week-­‐old	  male	  Holstein	  calves	  and	  10-­‐day	  old	  mixed-­‐breed	  pigs	  of	  both	  sexes.	  	  Animal	  experiments	  were	  approved	  by	  the	  Iowa	  State	  University	  Institutional	  Animal	  Care	  and	  Use	  Committee.	  
SstpNPG	  was	  chosen	  as	  a	  representative	  neuropathogenic	  strain.	  	  SstpSARB,	  which	  is	  unable	  to	  induce	  signs	  of	  neurologic	  disease,	  was	  also	  used	  to	  inoculate	  a	  control	  group.	  	  Bacteria	  were	  stored	  in	  cryopreservation	  tubes	  containing	  50%	  glycerol	  and	  50%	  Lennox	  L	  broth	  at	  -­‐80°C	  and	  were	  grown	  in	  or	  on	  Lennox	  L	  broth	  or	  culture	  agar	  prior	  to	  use.	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In	  vivo	  infection-­stress	  experiments	  involving	  neuropathogenic	  strains	  	   Animals	  were	  challenge-­‐exposed	  via	  oral	  administration	  of	  4.5	  X	  106	  CFUs	  of	  
SstpNPG/kg;	  these	  Salmonella	  organisms	  were	  grown	  aerobically	  for	  16	  hours	  at	  37°C.	  	  For	  each	  strain,	  3	  pigs	  and	  3	  calves	  received	  daily	  doses	  of	  norepinephrine	  (45	  µg/kg,	  IM)	  starting	  on	  the	  day	  of	  inoculation	  and	  continuing	  until	  the	  animals	  were	  euthanatized.	  	  As	  a	  neurohormonal	  control	  treatment,	  3	  calves	  and	  3	  pigs	  were	  challenge-­‐exposed	  by	  oral	  administration	  of	  SstpNPG	  and	  administered	  a	  placebo	  (volume	  of	  saline	  [0.9%	  NaCl]	  solution	  identical	  to	  the	  volume	  of	  norepinephrine,	  IM).	  	  Additionally,	  3	  calves	  and	  3	  pigs	  were	  challenge-­‐exposed	  by	  oral	  administration	  of	  
SstpNPG	  and	  administered	  daily	  doses	  of	  dexamethasone	  (0.1	  mg/kg,	  IM).	  	  The	  control	  strain,	  which	  was	  administered	  to	  3	  calves	  and	  3	  pigs,	  was	  SstpSARB,	  which	  is	  not	  capable	  of	  causing	  neurologic	  disease	  in	  cattle	  [3].	  Animals	  were	  monitored	  for	  neurologic	  disease	  (seizures	  or	  clinical	  signs	  such	  as	  excessive	  ear	  fluttering,	  ataxia,	  opisthotonus,	  and	  proprioceptive	  placing	  deficits).	  	  When	  signs	  of	  neurologic	  disease	  were	  observed	  (typically	  4	  to	  9	  days	  after	  inoculation),	  affected	  animals	  were	  immediately	  euthanatized.	  	  An	  animal	  with	  neurologic	  disease	  was	  defined	  as	  an	  animal	  that	  had	  convulsions	  or	  that	  had	  at	  least	  2	  of	  the	  aforementioned	  4	  clinical	  signs	  of	  neurologic	  disease.	  	  Animals	  that	  did	  not	  have	  signs	  of	  neurologic	  disease	  were	  euthanatized	  12	  to	  14	  days	  after	  inoculation	  (i.e.,	  at	  least	  3	  or	  4	  days	  after	  animals	  with	  signs	  of	  neurologic	  disease	  were	  euthanatized).	  	  Animals	  were	  euthanatized	  with	  xylazine	  and	  pentobarbital,	  as	  described	  previously.	  	  Samples	  of	  the	  intestines,	  blood,	  spleen,	  and	  brain	  were	  collected	  from	  each	  animal.	  
	   29	  
Bacteriologic-­based	  detection	  of	  Salmonella	  spp	  	   For	  qualitative	  assessment	  of	  Salmonella	  spp,	  microbes	  were	  selectively	  cultured	  by	  inoculation	  of	  3	  to	  5	  g	  of	  each	  sample	  into	  100	  mL	  of	  GN	  Hajna	  broth	  and	  incubation	  overnight	  at	  37	  °C	  in	  aerobic	  conditions.	  	  Then,	  100	  µL	  of	  the	  inoculum	  was	  transferred	  into	  5	  mL	  of	  Rappaport-­‐Vassiliadis	  R10	  broth,	  which	  was	  also	  incubated	  overnight	  at	  37°C	  in	  aerobic	  conditions.	  	  Cultures	  were	  then	  transferred	  to	  plates	  containing	  BGS	  agar;	  plates	  were	  incubated	  overnight	  at	  37°C.	  	  Individual	  colonies	  recovered	  from	  selective	  plates	  were	  grown	  overnight	  in	  Lennox	  L	  broth	  and	  identified	  by	  use	  of	  a	  
Salmonella-­‐specific	  PCR	  assay	  targeting	  the	  sipB-­‐sipC	  junction	  [2].	  	  All	  media	  included	  antimicrobials	  specific	  to	  the	  antibiogram	  of	  the	  individual	  isolate.	  For	  quantitation	  of	  Salmonella	  organisms	  in	  blood	  and	  spleen	  tissues	  as	  an	  estimate	  of	  systemic	  pathogen	  load	  and	  as	  an	  indirect	  correlate	  of	  clinical	  signs,	  samples	  were	  directly	  inoculated	  on	  plates	  containing	  BGS	  agar.	  	  For	  blood	  samples,	  100	  µL	  was	  inoculated	  onto	  each	  of	  10	  separate	  plates.	  	  For	  spleen	  samples,	  50	  to	  75	  g	  of	  sample	  was	  homogenized,	  filtered	  with	  cheesecloth,	  and	  then	  inoculated	  onto	  10	  plates	  containing	  BGS	  agar	  (i.e.,	  approx	  3	  to	  5	  g	  of	  sample/plate).	  	  Colonies	  were	  enumerated	  the	  following	  day.	  	  Because	  these	  tissues	  can	  harbor	  similar	  numbers	  of	  bacteria	  at	  early	  time	  points	  in	  the	  infectious	  process,	  CFU	  data	  for	  spleen	  samples	  were	  pooled	  with	  counts	  from	  blood	  samples	  to	  provide	  the	  final	  data	  of	  each	  time	  course	  experiment.	  	  The	  identity	  of	  Salmonella	  strains	  was	  confirmed	  by	  use	  of	  antisera-­‐agglutination–based	  serogrouping	  [1]	  in	  addition	  to	  confirmation	  of	  the	  original	  antibiogram	  for	  each	  isolate.	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RESULTS	  In	  vivo	  experiments	  were	  conducted	  to	  determine	  whether	  the	  SstpNPG	  strain	  could	  lead	  to	  neurologic	  disease	  in	  pigs,	  similar	  to	  that	  observed	  in	  stressed	  calves	  [3].	  	  
SstpNPG	  was	  inoculated	  into	  young	  calves	  and	  pigs,	  and	  these	  animals	  were	  also	  administered	  consecutive	  daily	  doses	  of	  norepinephrine	  or	  dexamethasone	  to	  mimic	  stress.	  	  As	  a	  control	  sample,	  animals	  were	  inoculated	  with	  SstpSARB,	  which	  is	  not	  capable	  of	  eliciting	  signs	  of	  neurologic	  disease	  in	  calves	  [3].	  Pigs	  did	  not	  have	  signs	  of	  clinical	  disease,	  and	  Salmonella	  organisms	  could	  only	  be	  recovered	  from	  the	  intestines	  (Table	  1).	  	  In	  contrast,	  calves	  had	  signs	  of	  neurologic	  disease	  when	  inoculated	  with	  SstpNPG	  and	  administered	  norepinephrine	  or	  dexamethasone.	  	  Salmonella	  organisms	  were	  isolated	  from	  the	  intestines,	  blood,	  spleen,	  and	  brain	  of	  calves	  with	  signs	  of	  neurologic	  disease.	  	  Non-­‐neuropathogenic	  SstpSARB	  was	  only	  recovered	  from	  the	  intestines	  of	  calves,	  similar	  to	  results	  in	  another	  study	  [3].	  	  DISCUSSION	  	   Several	  unique	  strains	  of	  Salmonella	  spp	  have	  unusual	  virulence	  and	  pathogenicity	  properties	  in	  calves.	  	  However,	  these	  effects	  have	  not	  been	  confirmed	  clinically	  in	  pigs.	  	  Neuropathogenicity	  have	  been	  associated	  with	  specific	  strains	  of	  
Salmonella	  spp	  under	  certain	  conditions.	  	  Stress	  has	  been	  implicated	  in	  the	  etiology	  of	  the	  encephalopathies	  related	  to	  the	  neuropathogenic	  Salmonella	  spp.	  	  SstpNPG	  caused	  neurologic	  disease	  in	  cattle,	  but	  similar	  effects	  were	  not	  observed	  in	  pigs.	  	  This	  finding	  is	  not	  altogether	  surprising	  because	  the	  Salmonella-­‐associated	  neuropathogenicity	  
	   31	  
appears	  to	  be	  dependent	  on	  neurohormonal	  factors	  in	  cattle	  that	  may	  be	  divergent	  from	  those	  in	  swine.	  	  Overall,	  Salmonella	  strains	  are	  typically	  more	  virulent	  in	  cattle.	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Table	  1.	  	  Qualitative	  assessment	  of	  Salmonella	  organisms	  recovered	  from	  male	  Holstein	  calves	  and	  male	  and	  female	  mixed-­‐breed	  pigs	  inoculated	  with	  S.	  enterica	  serotype	  SaintpaulNPG	  or	  non-­‐neuropathogenic	  Salmonella	  SaintpaulSARB	  and	  injected	  with	  norepinephrine	  or	  dexamethasone	  to	  simulate	  stress.	  	   Cattle	   Swine	  	   Tissue	  source	   Tissue	  source	  Strain	   Treatment	   In	   Bl-­‐S	   Br	   Neurologic	  disease*	   In	   Bl-­‐S	   Br	   Neurologic	  disease*	  Saline**	   A	   NI	   NI	   A	   A	   NI	   NI	   NI	  Norepinephrine	   A	   A	   A	   A	   A	   NI	   NI	   NI	  SstpNPG	   Dexamethasone	   A	   B	   B	   B	   A	   NI	   NI	   NI	  SstpSARB	   Norepinephrine	   A	   NI	   NI	   NI	   A	   NI	   NI	   NI	  	  *	  Neurologic	  disease	  was	  defined	  as	  animals	  that	  had	  convulsions	  or	  that	  had	  at	  least	  2	  of	  4	  clinical	  signs	  of	  neurologic	  disease	  (excessive	  ear	  fluttering,	  ataxia,	  opisthotonus,	  and	  proprioceptive	  placing	  deficits)	  **	  0.9%	  NaCl	  solution	  A	  =	  Isolated	  or	  observed	  in	  all	  3	  animals	  	  B	  =	  Isolated	  or	  observed	  in	  2	  of	  3	  animals	  Bl-­‐S	  =	  Blood	  and	  spleen	  combined	  Br	  =	  Brain	  In	  =	  Intestines	  NI	  =	  Not	  isolated	  or	  identified	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CHAPTER	  3.	  EXPRESSION	  OF	  A	  COLLAGENASE	  THAT	  ENABLES	  BLOOD-­BRAIN	  
BARRIER	  PENETRATION	  FOR	  SALMONELLA	  IMPLICATED	  IN	  BOVINE	  
ENCEPHALOPATHIES	  	  
	  Modification	  of	  a	  paper	  in	  submission	  to	  	  
Microbial	  Pathogenesis	  	  Nalee	  Xiong,	  Matthew	  T.	  Brewer,	  Kristi	  L.	  Anderson,	  Katharine	  E.	  Weeks,	  	  and	  Steve	  A.	  Carlson	  	  ABSTRACT	  Recent	  studies	  identified	  strains	  of	  Salmonella	  that	  induce	  encephalopathies	  in	  calves	  exposed	  to	  stressful	  situations.	  	  In	  order	  to	  cause	  neurologic	  signs	  (such	  as	  ataxia,	  head	  tilt,	  and	  partial	  blindness),	  the	  strain	  must	  be	  able	  to	  cross	  the	  blood-­‐brain	  barrier	  (BBB).	  	  One	  possible	  way	  is	  through	  the	  breakdown	  of	  tight	  junctions,	  which	  regulate	  the	  permeability	  of	  the	  BBB	  and	  can	  be	  weakened	  by	  enzymes	  such	  as	  collagenases.	  	  Salmonella	  and	  other	  Gram-­‐negative	  bacteria	  contain	  a	  collagenase	  gene	  (clg)	  that	  is	  silenced	  in	  vitro	  but	  inducibly	  expressed	  in	  vivo.	  	  We	  hypothesized	  that	  the	  neuropathic	  strains	  of	  Salmonella	  express	  clg	  in	  response	  to	  neuroendocrine	  factors	  in	  the	  host	  and	  that	  the	  expressed	  collagenase	  perturbs	  the	  BBB	  allowing	  for	  CNS	  invasion	  by	  Salmonella.	  	  Our	  in	  vitro	  results	  revealed	  that	  clg	  is	  derepressed	  in	  serum	  obtained	  from	  stressed	  cattle.	  	  Derepression	  is	  relegated	  to	  the	  neuropathic	  Salmonella	  strains.	  	  
In	  vivo	  studies	  indicated	  that	  clg	  expression	  is	  required	  for	  neuropathogenicity	  and	  that	  pharmacologic	  maintenance	  of	  the	  BBB	  prevents	  both	  the	  Salmonella	  invasion	  into	  the	  brain	  and	  the	  resulting	  neurologic	  signs.	  	  These	  studies	  identify	  a	  host-­‐induced	  
Salmonella	  collagenase	  that	  facilitates	  neuropathogenicity	  at	  the	  level	  of	  the	  BBB.	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INTRODUCTION	  
Salmonella	  infections	  are	  a	  continuous	  concern	  for	  human	  medicine,	  veterinary	  medicine,	  and	  food	  safety.	  	  Salmonellosis	  is	  based	  on	  the	  ability	  of	  the	  bacterium	  to	  secrete	  toxins,	  invade	  host	  cells,	  and	  survive	  within	  macrophages	  [6,	  13].	  	  Systemic	  salmonellosis	  is	  a	  common	  outcome	  and	  neurologic	  disease	  is	  a	  rare	  yet	  devastating	  sequela	  for	  typhoidal	  and	  paratyphoidal	  serotypes	  that	  are	  adapted	  and/or	  restricted	  to	  certain	  hosts	  [4].	  	  Non-­‐typhoidal	  encephalopathies	  are	  very	  rare	  but	  we	  identified	  three	  non-­‐typhoidal	  isolates	  capable	  of	  causing	  encephalopathies	  in	  stressed	  calves.	  	  A	  neuropathogenic	  isolate	  of	  Salmonella	  enterica	  serovar	  Saintpaul	  (SstpNPG)	  was	  isolated	  from	  a	  four-­‐month	  old	  Holstein	  calf	  exhibiting	  signs	  of	  encephalopathy	  in	  2002	  [9]	  and	  this	  isolate	  is	  the	  paradigm	  for	  the	  studies	  described	  herein.	  	  Our	  previous	  studies	  [9]	  revealed	  that	  SstpNPG	  is	  present	  in	  the	  brains	  of	  calves	  displaying	  neurologic	  signs	  suggesting	  that	  this	  isolate	  traverses	  the	  blood-­‐brain	  barrier	  (BBB).	  	  This	  phenomenon	  occurred	  in	  the	  absence	  of	  overt	  CNS	  inflammation	  that	  typically	  compromises	  the	  BBB	  leading	  to	  typhoidal	  encephalopathies.	  	  Therefore,	  it	  appears	  that	  SstpNPG	  must	  circumvent	  the	  BBB	  in	  an	  alternative	  manner.	  	  The	  BBB	  is	  comprised	  of	  tight	  junctions	  and	  adherens	  junctions	  between	  blood	  vessels	  and	  a	  basement	  membrane	  composed	  of	  type	  IV	  collagen,	  laminin,	  proteoglycan,	  glycoproteins,	  and	  astroglial	  end	  feet	  [1,	  5].	  	  Depletion	  of	  tight	  junctions	  and	  degradation	  of	  the	  basement	  membrane	  can	  lead	  to	  a	  paracellular	  route	  through	  the	  BBB	  and	  into	  the	  brain.	  	  	  Therefore,	  a	  collagenase	  may	  be	  able	  to	  mediate	  this	  process.	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Our	  previous	  studies	  revealed	  that	  a	  Salmonella	  collagenase	  causes	  atypical	  salmonellosis	  in	  veal	  calves	  reared	  in	  confined	  spaces,	  i.e.,	  stressed	  animals	  [13].	  	  Since	  
SstpNPG	  only	  induces	  neuropathogenicity	  in	  stressed	  calves,	  we	  set	  out	  to	  determine	  if	  
clg	  plays	  a	  role	  in	  SstpNPG	  translocation	  across	  the	  BBB	  and	  whether	  the	  derepression	  of	  clg	  results	  from	  specific	  neuroendocrine	  hormone	  interactions.	  	  MATERIALS	  AND	  METHODS	  
Bacterial	  strains	  
SstpNPG	  and	  SstpSARB	  were	  as	  described	  previously	  [9].	  	  SstpNPG	  was	  also	  transformed	  with	  a	  pCRXL	  plasmid	  bearing	  clg	  (pAs-­‐Clg)	  oriented	  in	  the	  antisense	  direction,	  serving	  to	  knock	  down	  the	  gene	  expression	  in	  the	  recombinant	  isostrain	  [13].	  	  HB101,	  a	  laboratory	  strain	  of	  E.	  coli	  (Invitrogen),	  was	  transformed	  with	  a	  plasmid	  that	  constitutively	  expresses	  collagenase	  (pClg)	  from	  the	  lac	  promoter	  on	  pCRXL	  (Invitrogen)	  [13].	  	  	  
In	  vitro	  experiments	  assessing	  clg	  derepression	  A	  recently	  transported	  Angus	  steer	  provided	  the	  “stressed”	  serum	  while	  an	  adult	  dairy	  cow	  provided	  the	  “unstressed”	  serum.	  	  Serum	  and	  LB	  broth	  were	  mixed	  1:1	  and	  108	  CFUs	  of	  bacteria	  were	  added	  to	  the	  mixture.	  	  To	  test	  the	  effects	  of	  neuroendocrine	  hormones,	  norepinephrine	  (50	  µg/mL;	  Sigma)	  and	  dexamethasone	  (100	  µg/mL;	  Sigma)	  were	  individually	  added	  to	  2	  mL	  of	  LB	  broth	  containing	  108	  CFUs	  of	  bacteria.	  	  HB101-­‐pClg	  was	  grown	  in	  2	  mL	  of	  LB	  broth	  with	  no	  treatment	  and	  served	  as	  the	  positive	  control	  for	  clg	  expression.	  	  All	  incubations	  were	  performed	  aerobically	  at	  37oC	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overnight.	  	  SstpNPG	  was	  grown	  in	  the	  presence	  of	  8	  µg/ml	  of	  ceftiofur	  since	  this	  isolate	  expresses	  an	  extended-­‐spectrum	  beta-­‐lactamase.	  	  SstpNPG/pAs-­‐Clg	  and	  HB101-­‐pClg	  were	  grown	  in	  the	  presence	  of	  32	  µg/ml	  of	  kanamycin	  since	  the	  pAs-­‐Clg	  and	  pClg	  plasmids	  contain	  a	  kanamycin	  resistance	  marker.	  Following	  the	  incubation,	  RNA	  was	  isolated	  from	  the	  bacteria	  grown	  using	  the	  RNeasy	  kit	  (Invitrogen)	  in	  order	  to	  determine	  the	  expression	  of	  collagenase	  via	  RT-­‐PCR.	  	  The	  OneStep	  RT-­‐PCR	  kit	  was	  used	  with	  the	  following	  oligonucleotide	  primers:	  ClgF	  (5’-­‐AGGACTGTATGCGCGCCAGCAAC-­‐3’)	  and	  ClgR	  (5’-­‐GTCGACCTCGAGTTAAACGCCCTGCGCTT	  CGG-­‐3’).	  	  Thermocycling	  was	  as	  follows:	  55°C	  for	  30	  minutes,	  94°C	  for	  2	  minutes,	  and	  then	  40	  cycles	  of	  94°C	  for	  15	  seconds,	  55°C	  for	  30	  seconds,	  and	  68	  degrees	  for	  1	  minute.	  
In	  vivo	  experiments	  
In	  vivo	  experiments	  involved	  Holstein	  calves	  1	  to	  5	  weeks	  of	  age	  (30	  to	  60	  kg).	  	  	  All	  subjects	  were	  pharmacologically	  stressed	  through	  daily	  intramuscular	  injections	  of	  norepinephrine	  as	  per	  McCuddin	  et	  al.	  [9].	  	  Eight	  calves	  were	  orally	  challenged	  with	  1	  mL	  inoculum	  containing	  109	  CFUs	  of	  SstpNPG,	  which	  was	  grown	  aerobically	  overnight	  for	  16	  hours	  at	  37°C.	  	  Four	  of	  these	  calves	  served	  as	  the	  control	  group	  and	  received	  no	  additional	  treatments	  while	  the	  other	  group	  of	  four	  calves	  received	  cilostazol	  (Sigma	  Chemicals;	  1	  mg/kg,	  IM,	  s.i.d.;	  [3]).	  	  An	  additional	  four	  calves	  received	  a	  strain	  of	  
SstpNPG	  in	  which	  clg	  is	  transiently	  knocked	  down	  via	  an	  antisense	  expression	  plasmid	  (pAs-­‐Clg).	  	  The	  final	  group	  of	  four	  calves	  were	  inoculated	  with	  the	  SstpSARB	  isostrain	  that	  does	  not	  elicit	  neurologic	  disease	  [9].	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Indications	  of	  the	  nervous	  system	  being	  compromised	  were	  observed	  through	  behavioral	  aberrations	  such	  as	  head	  tilt,	  ataxia	  and	  other	  movement	  anomalies.	  	  Calves	  were	  euthanized	  immediately	  after	  showing	  signs	  of	  neurologic	  disease	  (3	  to	  6	  days	  post-­‐infection)	  and	  those	  that	  did	  not	  display	  encephalopathy	  were	  euthanized	  8	  to	  10	  days	  post-­‐infection.	  	  	  Euthanasia	  was	  performed	  using	  xylazine	  (0.45	  mg/kg,	  IM,	  Phoenix	  Laboratories)	  and	  pentobarbital	  (1.2	  mg/kg,	  IV,	  Fort	  Dodge	  Laboratories).	  	  Animal	  experiments	  were	  approved	  by	  the	  Institutional	  Animal	  Care	  and	  Use	  Committee	  at	  Iowa	  State	  University	  (protocol	  1-­‐08-­‐6508B).	  
Qualitative	  Salmonella	  assessment	  Blood	  (10	  mL)	  and	  brain	  (10	  g)	  samples	  were	  collected	  for	  the	  qualitative	  isolation	  of	  Salmonella.	  	  Samples	  were	  enriched	  in	  a	  50	  mL	  falcon	  tube	  and	  grown	  statically	  overnight	  at	  37°C	  in	  10	  mL	  of	  LB	  broth	  with	  no	  antibiotics.	  	  Salmonella	  colonies	  were	  selectively	  cultured	  and	  isolated	  on	  brilliant	  green	  agar	  plates	  containing	  8	  µg/mL	  of	  ceftiofur.	  	  Colonies	  were	  identified	  using	  Salmonella-­‐specific	  PCR	  targeting	  the	  sipB-­sipC	  junction	  [13].	  	  RESULTS	  
Assessment	  of	  host	  neuroendocrine	  hormones	  on	  clg	  expression	  
	   In	  order	  to	  determine	  if	  there	  is	  a	  relationship	  between	  host	  neuroendocrine	  hormones	  and	  clg	  derepression,	  both	  SstpNPG	  and	  a	  SARB	  control	  Sstp	  strain	  [7]	  were	  grown	  in	  nutrient	  broth	  containing	  serum	  from	  stressed	  or	  unstressed	  cattle.	  	  Additionally,	  both	  SstpNPG	  and	  the	  control	  SstpSARB	  strain	  were	  grown	  in	  broth	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containing	  either	  norepinephrine	  or	  dexamethasone.	  	  HB101-­‐pClg,	  an	  E.	  coli	  that	  constitutively	  expresses	  recombinant	  clg,	  was	  grown	  in	  untreated	  broth	  as	  a	  positive	  control	  for	  clg	  expression.	  	  Each	  condition	  was	  conducted	  in	  2	  mL	  broth	  mixtures	  that	  were	  aerobically	  grown	  for	  16	  hours	  overnight	  at	  37°C	  in	  a	  tabletop	  shaker.	  	  RNA	  was	  then	  isolated	  and	  used	  as	  the	  template	  to	  determine	  whether	  the	  clg	  was	  derepressed.	  	  As	  shown	  in	  Figure	  1,	  RT-­‐PCR	  assays	  indicated	  that	  clg	  was	  only	  transcribed	  in	  the	  presence	  of	  stressed	  calf	  serum.	  	  Neither	  norepinephrine	  nor	  dexamethasone	  was	  able	  to	  solely	  derepress	  gene	  expression.	  
Repression	  of	  clg	  prevented	  SstpNPG	  from	  traversing	  the	  BBB	  In	  order	  to	  determine	  if	  there	  is	  a	  direct	  relationship	  between	  clg	  and	  the	  success	  of	  the	  strain	  at	  traversing	  the	  BBB,	  calves	  were	  pharmacologically	  stressed	  (using	  norepinephrine)	  and	  orally	  challenged	  with	  an	  isostrain	  of	  SstpNPG	  incapable	  of	  expressing	  clg.	  	  	  As	  shown	  in	  Table	  1,	  repression	  of	  clg	  obviated	  neurologic	  disease	  and	  BBB	  penetration	  of	  SstpNPG	  that	  was	  recovered	  from	  the	  systemic	  circulation.	  
Cilostazol	  prevents	  SstpNPG	  from	  traversing	  the	  BBB	  	  In	  order	  to	  determine	  if	  SstpNPG	  elicits	  changes	  in	  the	  BBB,	  calves	  were	  inoculated	  with	  SstpNPG	  and	  treated	  with	  norepinephrine	  and	  cilostazol.	  	  Cilostazol	  maintains	  the	  integrity	  of	  the	  BBB	  by	  increasing	  intracellular	  cAMP	  concentrations	  through	  the	  selective	  inhibition	  of	  phosphodiesterase	  III	  [7,	  8].	  	  As	  shown	  in	  Table	  1,	  cilostazol	  prevented	  neurologic	  disease	  and	  BBB	  penetration	  of	  SstpNPG.	  	  As	  observed	  with	  repression	  of	  clg	  in	  the	  clg-­‐knockdown	  isostrain,	  SstpNPG	  was	  recovered	  from	  the	  systemic	  circulation	  in	  cilostazol-­‐treated	  calves	  but	  was	  not	  isolated	  from	  calf	  brains.	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DISCUSSION	  Our	  in	  vitro	  experiments	  demonstrated	  that	  derepression	  of	  clg	  specifically	  involved	  host	  neuroendocrine	  hormone	  elements.	  	  Though	  our	  results	  indicate	  this	  derepression	  is	  not	  specifically	  due	  to	  norepinephrine	  or	  cortisol	  (represented	  by	  dexamethasone)	  alone,	  it	  is	  possible	  that	  both	  still	  play	  a	  role.	  Stress	  leads	  to	  the	  activation	  of	  the	  autonomic	  nervous	  system	  and	  hypothalamo-­‐pituitary-­‐adrenal	  (HPA)	  axis.	  	  There	  are	  a	  number	  of	  mediators	  aside	  from	  catecholamines	  and	  glucocorticoids	  that	  play	  a	  role	  in	  how	  the	  body	  reacts	  to	  stress,	  whereby	  each	  mediator	  has	  the	  ability	  to	  regulate	  the	  activity	  of	  other	  mediators	  in	  a	  network	  [10].	  	  Many	  studies	  have	  determined	  a	  connection	  between	  host	  neuroendrocrine	  stress	  hormones	  and	  increased	  bacterial	  virulence	  but	  little	  is	  known	  on	  its	  role	  in	  derepression	  of	  clg.	  	  Due	  to	  the	  complexity	  and	  little	  research	  conducted	  on	  this	  physiological	  process,	  further	  experiments	  need	  to	  be	  conducted	  to	  address	  the	  relationship	  between	  neuroendocrine	  hormones	  and	  the	  derepression	  of	  clg.	  	  	  	  
In	  vivo	  experiments	  demonstrated	  that	  clg	  was	  essential	  for	  inducing	  neuropathogenicity	  and	  repressing	  clg	  resulted	  in	  bacteria	  remaining	  in	  the	  systemic	  circulation.	  	  Maintaining	  the	  integrity	  of	  the	  BBB	  also	  prevented	  neurologic	  disease	  by	  sequestering	  the	  pathogen	  in	  the	  systemic	  circulation.	  	  These	  results	  suggest	  that	  the	  collagenase	  cleaves	  tight	  junctions	  allowing	  for	  bacterial	  penetration	  into	  the	  brain	  via	  a	  paracellular	  route.	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SstpNPG	   None	   Positive	   Positive	   Yes	   Yes	  
SstpNPG	   Cilostazol	   Positive	   Negative	   None	   Yes	  
SstpNPG/	  pAs-­‐Clg	   None	   Positive	   Negative	   None	   No	  
SstpSARB	   None	   Positive	   Negative	   None	   No	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CHAPTER	  4.	  BETA-­LACTAM	  ANTIBIOTICS	  PREVENT	  SALMONELLA-­
MEDIATED	  ENCEPHALOPATHY	  REGARDELSS	  OF	  BETA-­LACTAM	  
RESISTANCE	  	  Modification	  of	  a	  paper	  in	  submission	  to	  	  
The	  Veterinary	  Journal	  
	  Nalee	  Xiong,	  Matt	  T.	  Brewer,	  Kristi	  L.	  Anderson,	  Gwyneth	  Watrous,	  Katharine	  E.	  Weeks,	  Alison	  E.	  Barnhill,	  Tim	  A.	  Day,	  Michael	  J.	  Kimber,	  and	  Steve	  A.	  Carlson	  	  	  ABSTRACT	  Nontyphoidal	  Salmonella	  encephalopathies	  (NTSE)	  are	  a	  rare	  but	  serious	  extraintestinal	  manifestation	  of	  salmonellosis.	  	  Recently,	  we	  identified	  three	  unique	  strains	  of	  Salmonella	  that	  elicited	  neurologic	  disease	  in	  a	  bovine	  stress	  model,	  and	  this	  neurologic	  disease	  appears	  to	  be	  due	  to	  a	  neuroexcitation	  in	  the	  absence	  of	  overt	  brain	  histopathology.	  	  Recent	  studies	  suggest	  that	  beta-­‐lactam	  antibiotics	  can	  exert	  neuroprotective	  effects,	  independent	  of	  bacteriocidal	  activities,	  by	  increasing	  glutamate	  export	  from	  the	  brain.	  	  Since	  glutamate	  is	  a	  neuroexcitant,	  we	  evaluated	  two	  bovine-­‐approved	  beta-­‐lactam	  antibiotics	  as	  interventions	  for	  bovine	  NTSE.	  	  Using	  a	  previously	  described	  norepinephrine-­‐based	  stress	  model,	  calves	  were	  infected	  with	  a	  clinical	  strain	  of	  beta-­‐lactam-­‐resistant	  Salmonella	  enterica	  serotype	  Saintpaul	  (SstpNPG)	  and	  divided	  into	  seven	  groups.	  	  Two	  groups	  received	  a	  beta-­‐lactam	  (either	  ampicillin	  or	  ceftiofur)	  upon	  overt	  onset	  of	  salmonellosis	  (e.g.	  diarrhea).	  	  A	  third	  group	  received	  a	  beta-­‐lactam	  antibiotic	  plus	  a	  glutamate	  export	  inhibitor.	  	  The	  fourth	  group	  received	  MK-­‐801,	  a	  glutamate	  receptor	  antagonist,	  instead	  of	  an	  antibiotic.	  	  The	  fifth	  and	  sixth	  groups	  received	  non-­‐beta-­‐lactam	  antibiotics	  with	  either	  putative	  neuroprotective	  effects	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(minocycline)	  or	  known	  bacteriocidal	  effects	  (enrofloxacin).	  	  The	  final	  group	  received	  only	  norepinephrine.	  	  Neurologic	  disease	  was	  observed	  in	  three	  groups	  -­‐	  calves	  injected	  with	  just	  norepinephrine,	  calves	  co-­‐treated	  with	  a	  beta-­‐lactam	  and	  a	  glutamate	  export	  inhibitor,	  and	  calves	  treated	  with	  minocycline.	  	  Interestingly,	  Salmonella	  were	  recovered	  from	  the	  brains	  of	  all	  calves	  except	  those	  treated	  with	  enrofloxacin.	  	  Glutamate	  exporter	  expression	  was	  elevated	  in	  calves	  treated	  with	  beta-­‐lactam	  antibiotics.	  	  These	  results	  support	  the	  use	  of	  beta-­‐lactams	  as	  effective	  therapeutics	  for	  bovine	  NTSE,	  regardless	  of	  extended-­‐spectrum	  beta-­‐lactamase	  activity.	  	  INTRODUCTION	  A	  clinical	  isolate	  of	  Salmonella	  enterica	  serovar	  Saintpaul	  (SstpNPG)	  was	  recently	  implicated	  in	  an	  outbreak	  of	  atypical	  bovine	  salmonellosis.	  	  In	  this	  instance	  of	  non-­‐typhoidal	  Salmonella	  encephalopathy	  (NTSE),	  SstpNPG	  was	  isolated	  from	  Holstein	  calves	  exhibiting	  diarrhea,	  head	  tilt,	  ataxia,	  auditory	  hyper-­‐responsiveness,	  and	  partial	  blindness.	  	  Under	  experimental	  conditions,	  signs	  of	  neuropathogenicity	  were	  reproduced	  in	  calves	  stressed	  with	  norepinephrine	  and	  orally	  challenged	  with	  SstpNPG	  [6].	  	  Clinical	  findings	  demonstrated	  that	  SstpNPG	  causes	  bovine	  encephalopathy	  in	  the	  absence	  of	  overt	  histopathologic	  changes	  in	  the	  central	  nervous	  system.	  	  	  Additionally,	  only	  one	  colony-­‐forming	  unit	  of	  SstpNPG	  was	  recovered	  from	  each	  10g	  of	  brain	  [6].	  	  Therefore,	  the	  observed	  neurologic	  signs	  could	  be	  related	  to	  Salmonella-­‐mediated	  neurochemical	  anomalies	  not	  detectable	  using	  standard	  histopathologic	  techniques.	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One	  such	  neurochemical	  candidate	  is	  glutamate	  since	  neuroexcitement	  can	  be	  related	  to	  fluctuations	  in	  the	  release	  of	  this	  neurotransmitter.	  	  Activation	  of	  glutamate	  receptors,	  on	  both	  neuronal	  and	  glial	  cells,	  leads	  to	  an	  over-­‐saturation	  of	  calcium	  influx	  and	  excess	  intracellular	  signaling	  (7,	  16)	  that	  may	  not	  be	  easily	  detectable	  during	  the	  peracute	  phase	  of	  NTSE	  manifested	  in	  cattle.	  	  	  To	  evaluate	  the	  involvement	  of	  glutamate	  in	  SstpNPG-­‐mediated	  neuropathogenicity,	  we	  experimentally	  infected	  calves	  with	  this	  isolate	  and	  treated	  these	  animals	  with	  a	  pharmacologic	  stress	  mediator	  and	  compounds	  that	  inhibit	  the	  effects	  of	  glutamate.	  	  	  Specifically,	  glutamate	  activity	  was	  targeted	  for	  inhibition	  by	  treating	  infected	  animals	  with	  either	  MK-­‐801	  or	  beta-­‐lactam	  antibiotics.	  	  MK-­‐801	  is	  a	  selective	  and	  non-­‐competitive	  antagonist	  for	  N-­‐methyl-­‐D-­‐aspartate	  (NMDA)	  receptors,	  an	  ionotropic	  glutamate	  receptor	  [2,	  15],	  while	  beta-­‐lactam	  antibiotics	  were	  recently	  demonstrated	  to	  be	  neuroprotective	  by	  facilitating	  the	  export	  of	  glutamate	  from	  the	  brain	  via	  glial	  cells.	  	  Beta-­‐lactam	  antibiotics	  upregulate	  glutamate	  transporter-­‐1	  (GLT-­‐1)	  expression	  whereby	  GLT-­‐1	  promoter	  activity	  is	  enhanced	  in	  a	  concentration-­‐dependent	  and	  dose-­‐dependent	  manner	  by	  ceftriaxone	  (a	  third-­‐generation	  cephalosporin),	  amoxicillin	  (an	  aminopenicillin),	  and	  a	  number	  of	  other	  beta-­‐lactams	  [10].	  Considering	  these	  findings,	  we	  hypothesized	  that	  either	  MK-­‐801	  or	  beta-­‐lactam	  antibiotics	  will	  attenuate	  signs	  of	  neurologic	  disease	  in	  pharmacologically-­‐stressed	  calves	  infected	  with	  SstpNPG.	  	  Calves	  were	  experimentally	  challenged	  with	  SstpNPG,	  administered	  daily	  doses	  of	  norepinephrine,	  and	  then	  treated	  with	  either	  a	  beta-­‐lactam	  antibiotic,	  MK-­‐801,	  or	  the	  combination	  of	  a	  beta-­‐lactam	  and	  a	  glutamate	  export	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inhibitor.	  	  Additional	  groups	  of	  calves	  received	  non-­‐beta-­‐lactam	  antibiotics,	  minocycline	  or	  enrofloxacin,	  capable	  of	  penetrating	  the	  blood-­‐brain-­‐barrier.	  	  The	  former	  was	  chosen	  because	  of	  putative	  neuroprotective	  effects	  on	  neuronal	  apoptosis	  [5,	  9,	  13,	  14]	  while	  the	  latter	  antibiotic	  was	  selected	  as	  a	  control	  since	  it	  is	  not	  part	  of	  the	  antibiogram	  of	  
SstpNPG.	  	  These	  studies	  will	  determine	  the	  therapeutic	  value	  of	  beta-­‐lactams	  versus	  NTSE.	  	  MATERIALS	  AND	  METHODS	  
Bacterial	  strains	  used	  and	  preparation	  	   SstpNPG	  was	  obtained	  from	  calves	  that	  displayed	  the	  aforementioned	  clinical	  signs	  of	  neuropathogenicity	  [6].	  	  The	  isolate	  exhibits	  resistance	  to	  ampicillin,	  florfenicol/chloramphenicol,	  ceftriaxone/ceftiofur,	  and	  kanamycin.	  	  This	  strain	  is	  sensitive	  to	  tetracyclines	  and	  fluroquinolones.	  	  Prior	  to	  challenge,	  SstpNPG	  was	  grown	  statically	  overnight	  for	  16	  hours	  in	  LB	  broth	  containing	  8	  µg/mL	  of	  ceftiofur	  at	  37°C.	  	   Minocycline	  is	  a	  broad-­‐spectrum	  tetracycline	  antibiotic	  that	  functions	  as	  a	  bacteriostatic	  antibiotic	  and	  a	  neuroprotective	  agent	  that	  inhibits	  apoptosis	  via	  caspase-­‐1	  and	  caspase-­‐3	  inhibition	  and	  MMP9	  repression	  [5,	  9,	  13,	  14].	  	  More	  importantly,	  minocycline	  attenuates	  the	  activation	  of	  microglia,	  which	  is	  often	  associated	  with	  glutamate	  excitotoxicity	  [5,	  13,	  14].	  	  As	  a	  result,	  we	  were	  interested	  in	  its	  ability	  to	  abrogate	  the	  neurologic	  effects	  of	  SstpNPG.	  	  In	  order	  to	  make	  the	  SstpNPG	  isolate	  minocycline-­‐resistant,	  bacterial	  conjugation	  was	  conducted	  whereby	  minocycline-­‐resistance	  conjugative	  plasmids	  were	  transferred	  from	  a	  pool	  of	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minocycline-­‐resistant	  Salmonella	  SARB	  strains	  [8]	  to	  SstpNPG.	  	  Transconjugation	  occurred	  aerobically	  overnight	  at	  37°C	  in	  a	  1ml	  co-­‐inoculum	  containing	  5	  x	  108	  CFUs	  of	  
SstpNPG	  along	  with	  5	  x	  107	  CFUs	  of	  each	  nine	  different	  minocycline-­‐resistant	  SARB	  strains.	  	  To	  confirm	  conjugation,	  the	  liquid	  culture	  was	  inoculated	  into	  50	  mL	  of	  LB	  broth	  containing	  minocycline	  (16	  µg/mL)	  and	  ceftiofur	  (8	  µg/mL).	  	  Since	  the	  ceftiofur-­‐resistance	  plasmid	  was	  deemed	  to	  be	  non-­‐conjugative	  (data	  not	  shown)	  and	  thus	  not	  transferred	  from	  SstpNPG	  to	  the	  SARB	  strains,	  the	  resulting	  transconjugates	  were	  used	  to	  infect	  one	  group	  of	  calves.	  
In	  vivo	  experiments	  
In	  vivo	  experiments	  were	  conducted	  in	  Holstein	  or	  Jersey	  calves	  ranging	  from	  1	  to	  5	  weeks	  of	  age	  and	  weighing	  on	  average	  30-­‐60	  kg.	  	  Each	  calf	  received	  a	  1	  mL	  oral	  inoculum	  containing	  109	  CFUs	  of	  SstpNPG,	  or	  the	  minocycline-­‐resistant	  SstpNPG	  isostrain,	  which	  were	  grown	  aerobically	  for	  16	  hours	  at	  37°C.	  	  All	  subjects	  were	  also	  given	  daily	  injections	  of	  norepinephrine	  (20	  µg/kg,	  IM;	  Sigma)	  to	  imitate	  stress	  as	  per	  McCuddin	  et	  al.	  [2008].	  	  Three	  control	  subjects	  received	  no	  additional	  treatments	  while	  two	  groups	  of	  four	  subjects	  were	  each	  given	  a	  beta-­‐lactam	  [either	  ampicillin	  (5	  mg/kg,	  IM,	  s.i.d.;	  Polyflex®,	  Fort	  Dodge	  Laboratories)	  or	  ceftiofur	  (6.6	  mg/kg,	  subcutaneous;	  Excede®,	  Pfizer)]	  at	  the	  onset	  of	  diarrhea.	  	  Another	  group	  of	  four	  subjects	  were	  given	  either	  ampicillin	  (n	  =	  2)	  or	  ceftiofur	  (n	  =	  2)	  along	  with	  threo-­‐beta-­‐hydroxyaspartate	  (THA;	  0.1	  µg/kg,	  IM;	  Sigma),	  a	  glutamate	  exporter	  inhibitor	  [3,	  11,	  12].	  	  The	  effects	  of	  a	  glutamate	  receptor	  antagonist	  (MK-­‐801;	  0.4	  mg/kg,	  IM,	  s.i.d.;	  Sigma)	  was	  also	  evaluated	  in	  a	  separate	  group	  of	  three	  calves.	  	  The	  final	  two	  groups	  of	  calves	  (three	  calves	  per	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group)	  were	  given	  daily	  doses	  of	  either	  minocycline	  (10	  mg/kg,	  IM,	  s.i.d.;	  Sigma)	  or	  enrofloxacin	  (10mg/kg,	  subcutaneous;	  Baytril®,	  Bayer).	  	  Summarization	  of	  the	  above	  can	  be	  found	  on	  Table	  1.	  	  Once	  subjects	  displayed	  neurological	  signs	  (3	  to	  6	  days	  post	  infection),	  calves	  were	  euthanized	  immediately	  after	  photo-­‐documentation	  of	  neurologic	  signs.	  	  Calves	  that	  did	  not	  show	  signs	  of	  neurologic	  disease	  were	  euthanized	  8	  to	  10	  days	  post-­‐infection.	  	  Euthanasia	  was	  performed	  using	  xylazine	  (0.45	  mg/kg,	  IM;	  Phoenix	  Laboratories)	  and	  pentobarbital	  (1.2	  mg/kg,	  IV;	  Fort	  Dodge	  Laboratories).	  	  Animal	  experiments	  were	  approved	  by	  the	  Institutional	  Animal	  Care	  and	  Use	  Committee	  at	  Iowa	  State	  University	  (protocol	  2-­‐08-­‐6508B).	  	  
Qualitative	  isolation	  of	  Salmonella	  Blood	  (10	  mL)	  and	  brain	  (10	  g)	  samples	  were	  collected	  for	  the	  isolation	  of	  
Salmonella.	  	  Samples	  were	  enriched	  in	  a	  50	  mL	  falcon	  tube	  and	  grown	  statically	  overnight	  at	  37°C	  in	  10	  mL	  of	  LB	  broth	  with	  no	  antibiotics.	  	  Salmonella	  were	  selectively	  cultured	  by	  transferring	  20	  and	  200	  µL	  of	  LB	  broth	  culture	  to	  brilliant	  green	  agar	  plates	  containing	  8	  µg/mL	  of	  ceftiofur	  in	  order	  to	  isolate	  colonies.	  	  Following	  an	  overnight	  incubation	  at	  37°C,	  individual	  colonies	  were	  sampled	  from	  each	  plate	  and	  identified	  using	  Salmonella-­‐specific	  polymerase	  chain	  reaction	  (PCR)	  targeting	  the	  sipB-­sipC	  junction	  [1].	  	  
Semi-­quantification	  of	  GLT-­1	  RNA	  was	  isolated	  from	  brain	  cultures	  using	  the	  RNeasy	  Lipid	  Tissue	  Mini	  Kit	  (Qiagen).	  	  In	  order	  to	  quantify	  glutamate	  transporter-­‐1	  (GLT-­‐1)	  expression,	  semi-­‐
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quantitative	  RT-­‐PCR	  was	  conducted	  on	  RNA	  samples	  from	  calves	  using	  the	  following	  oligonucleotide	  primers:	  Glut1F	  5’	  –	  CATGCACAGAGAAGGCAAAA	  –	  3’	  and	  Glut1R	  5’	  –	  AGAGTCTCCATGGCCTCTGA	  –	  3’.	  	  Reactions	  were	  performed	  using	  Superscript	  III	  One-­‐Step	  RT-­‐PCR	  System	  with	  Platinum	  Taq	  (Invitrogen).	  	  The	  thermocyling	  program	  used	  was	  as	  follows:	  55°C	  for	  30	  minutes,	  94°C	  for	  2	  minutes,	  then	  either	  ran	  for	  10	  or	  40	  cycles	  of	  94°C	  for	  15	  seconds,	  45°C	  for	  30	  seconds,	  and	  68°C	  for	  30	  seconds.	  Amplicons	  were	  observed	  at	  various	  cycles	  using	  agarose	  gel	  electrophoresis.	  	  RESULTS	  
Assessment	  of	  neurologic	  disease	  in	  SstpNPG-­infected	  calves	  treated	  with	  beta-­lactam	  
antibiotics	  In	  order	  to	  determine	  if	  beta-­‐lactam	  antibiotics	  could	  prevent	  SstpNPG-­‐mediated	  neurologic	  disease,	  calves	  were	  inoculated	  with	  SstpNPG	  and	  treated	  with	  daily	  doses	  of	  norepinephrine.	  	  At	  the	  onset	  of	  diarrhea	  (one	  to	  two	  days	  post-­‐inoculation),	  calves	  were	  given	  standard	  FDA-­‐approved	  doses	  of	  either	  ceftiofur	  or	  ampicillin.	  	  Calves	  were	  then	  monitored	  for	  signs	  of	  neurologic	  disease	  such	  as	  seizures,	  opisthotonus,	  muscle	  fasciculations,	  ataxia,	  paddling,	  tonic-­‐clonic	  movements,	  and	  excessive	  ear	  fluttering	  as	  previous	  described	  [6].	  	  Calves	  that	  received	  a	  treatment	  of	  beta-­‐lactam	  antibiotics	  (either	  ceftiofur	  or	  ampicillin)	  showed	  no	  signs	  of	  neurologic	  disease	  (see	  Figure	  1).	  	  	  Additionally,	  one	  group	  of	  calves	  were	  administered	  a	  beta-­‐lactam	  antibiotic	  plus	  THA,	  a	  glutamate	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export	  inhibitor.	  	  This	  group	  of	  subjects	  did	  show	  signs	  of	  neurologic	  deficiencies	  in	  calves	  (see	  Figure	  1).	  	  	  
Assessment	  of	  GLT-­1	  expression	  in	  SstpNPG-­infected	  calves	  treated	  with	  beta-­lactam	  
antibiotics	  Since	  beta-­‐lactams	  provide	  neuroprotection	  by	  increasing	  the	  expression	  of	  glutamate	  transporters	  [4,	  10],	  we	  semi-­‐quantitatively	  assessed	  the	  expression	  of	  GLT-­‐1	  in	  SstpNPG-­‐infected	  calves	  that	  were	  treated	  with	  either	  ceftiofur	  or	  ampicillin.	  	  Brains	  were	  collected	  following	  euthanasia	  and	  semi-­‐quantitative	  RT-­‐PCR	  was	  performed	  using	  mRNA	  and	  oligonucleotide	  primers	  specific	  to	  GLT-­‐1	  transcripts.	  	  When	  compared	  to	  expression	  in	  calves	  that	  did	  not	  receive	  beta-­‐lactams,	  GLT-­‐1	  expression	  was	  elevated	  in	  calves	  treated	  with	  either	  ceftiofur	  or	  ampicillin	  (see	  Figure	  1).	  
Assessment	  of	  neurologic	  disease	  in	  SstpNPG-­infected	  calves	  treated	  with	  a	  glutamate	  
receptor	  antagonist	  In	  order	  to	  determine	  if	  the	  SstpNPG-­‐mediated	  neurologic	  effects	  are	  associated	  with	  elevations	  in	  brain	  glutamate	  activity,	  SstpNPG-­‐infected	  calves	  were	  treated	  with	  the	  ionotropic	  glutamate	  receptor	  antagonist	  MK-­‐801	  [2,	  15].	  	  As	  shown	  in	  Figure	  1,	  MK-­‐801-­‐treated	  calves	  did	  not	  display	  neurologic	  signs	  even	  though	  SstpNPG	  was	  present	  in	  the	  brains	  of	  these	  calves.	  
Assessment	  of	  neurologic	  disease	  in	  SstpNPG-­infected	  calves	  treated	  with	  non-­beta-­lactam	  
antibiotics	  The	  proposed	  neuroprotective	  effects	  of	  beta-­‐lactams	  are	  independent	  of	  their	  antibacterial	  activities.	  	  Therefore,	  a	  control	  group	  of	  SstpNPG-­‐infected	  calves	  were	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treated	  with	  either	  minocycline	  or	  enrofloxacin	  at	  the	  onset	  of	  diarrhea.	  	  Minocycline	  is	  a	  neuroprotective	  tetracycline	  antibiotic	  that	  inhibits	  neuronal	  apoptosis	  [5,	  13,	  14].	  	  Enrofloxacin	  was	  chosen	  since	  it	  is	  a	  bovine-­‐approved	  fluoroquinolone	  with	  no	  known	  neuroprotective	  activities	  and	  it	  is	  not	  part	  of	  the	  SstpNPG	  antibiogram.	  	  Neurologic	  disease	  and	  brain	  infection	  were	  noted	  in	  minocycline-­‐treated	  calves	  whereas	  enrofloxacin-­‐treated	  calves	  did	  not	  display	  neuropathy	  or	  brain	  infection	  (see	  Figure	  1).	  	  DISCUSSION	  In	  this	  study,	  we	  assessed	  the	  neuroprotective	  ability	  of	  beta-­‐lactam	  antibiotics	  in	  a	  model	  of	  calves	  infected	  with	  SstpNPG.	  	  We	  demonstrated	  that	  subjects	  given	  beta-­‐lactam	  antibiotics	  did	  not	  show	  signs	  of	  neurologic	  disease	  despite	  the	  isolate	  being	  resistant	  to	  the	  antibiotics.	  	  In	  beta-­‐lactam-­‐treated	  calves,	  SstpNPG	  could	  still	  traverse	  the	  blood-­‐brain	  barrier	  without	  causing	  neuropathogenicity	  unless	  a	  glutamate	  export	  inhibitor	  was	  co-­‐administered.	  	  Calves	  treated	  with	  a	  glutamate	  receptor	  antagonist	  also	  did	  not	  display	  neurologic	  signs.	  	  Beta-­‐lactam-­‐treated	  calves	  had	  increased	  expression	  of	  GLT-­‐1,	  a	  protein	  that	  facilitates	  glutamate	  export	  from	  the	  brain.	  	  Therefore,	  it	  appears	  that	  SstpNPG	  causes	  bovine	  neurologic	  disease	  through	  a	  glutamate-­‐dependent	  mechanism	  and	  that	  beta-­‐lactam	  antibiotics	  ameliorate	  these	  effects.	  	  	  Enrofloxacin	  was	  able	  to	  prevent	  neuropathogenicity	  through	  conventional	  bactericidal	  activities	  since	  SstpNPG	  was	  not	  found	  in	  the	  brains	  of	  calves	  treated	  with	  this	  drug.	  	  The	  neuroprotective	  effects	  of	  minocycline,	  however,	  did	  not	  alter	  the	  course	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of	  SstpNPG-­‐mediated	  disease	  indicating	  that	  signs	  of	  neuropathogenicity	  may	  not	  result	  from	  NMDA	  excitotoxicity	  triggered	  by	  the	  activation	  of	  microglia	  through	  p38	  [5,	  13,	  14].	  	   In	  summary,	  our	  study	  demonstrates	  that	  the	  neurologic	  effects	  of	  SstpNPG	  can	  be	  abolished	  by	  beta-­‐lactam	  antibiotics	  regardless	  of	  resistance.	  	  The	  mechanism	  by	  which	  neuroprotection	  occurs	  is	  through	  the	  increase	  of	  glutamate	  transporter	  expression.	  	  Beta-­‐lactams	  are	  therefore	  at	  least	  an	  adjunct	  therapy	  to	  be	  used	  versus	  bovine	  salmonellosis	  in	  order	  to	  prevent	  NTSE.	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Table	  1.	  Summary	  of	  in	  vivo	  experimental	  group	  treatment	  set	  up.	  	  Grps	   Strain	   NE	   Antibiotics	   GEI	   n	  1	   SstpNPG	   -­‐-­‐	   -­‐-­‐	   -­‐-­‐	   3	  2	   SstpNPG	   x	   -­‐-­‐	   -­‐-­‐	   4	  3	   SstpNPG	   x	   Amp	   -­‐-­‐	   4	  4	   SstpNPG	   x	   Cf	   x	   4	  5	   SstpNPG	   x	   Amp/Cf	   x	   4	  6	   SstpNPG	   x	   Enro	   x	   3	  7	   SstpSARB	   x	   -­‐-­‐	   x	   4	  8	   SstpNPG(MR)	   x	   Mino	   -­‐-­‐	   3	  	  NE	  =	  norepinephrine,	  GEI	  =	  glutamate	  exporter	  inhibitor,	  threo-­‐beta-­‐hydroxyaspartate,	  N	  =	  number	  of	  subjects	  per	  group,	  SstpNTX	  =	  Salmonella	  enterica	  serovar	  Saint	  Paul,	  SARB	  =	  Salmonella	  Reference	  Collection	  B,	  MR	  =	  minocycline-­‐resistant,	  Amp	  =	  ampicillin,	  Cf	  =	  ceftiofur,	  Enro	  =	  enrofloxacin	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Fig.	  1.	  	  	  Assessment	  of	  Salmonella	  blood	  and	  brain	  culture,	  GLT-­‐1	  hyperexpression,	  and	  neurologic	  signs	  in	  calves	  inoculated	  with	  SstpNTX	  and	  injected	  with	  norepinephrine.	  	  Additional	  treatments	  are	  indicated	  on	  the	  y-­‐axis:	  MK-­‐801,	  glutamate	  receptor	  antagonist;THA,	  threo-­‐beta-­‐hydroxyaspartate,	  a	  glutamate	  export	  inhibitor.	  	  The	  Score	  is	  the	  sum	  of	  1	  arbitrary	  unit	  for	  positive	  Salmonella	  blood	  culture,1	  arbitrary	  unit	  for	  positive	  Salmonella	  brain	  culture,	  1	  arbitrary	  unit	  for	  semi-­‐quantitative	  detection	  of	  GLT-­‐1	  hyperexpression	  in	  brain	  tissues,	  and	  1	  arbitrary	  unit	  for	  exhibiting	  at	  least	  four	  of	  the	  following	  six	  neurologic	  signs:	  paddling,	  proprioceptive	  placing	  deficits,	  excessive	  ear	  fluttering,	  ataxia,	  tremors,	  or	  opisthotonus	  as	  per	  McCuddin	  et	  al.	  (2008).	  	  Each	  treatment	  group	  represents	  three	  or	  four	  animals.	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CHAPTER	  5.	  THE	  LIPOPOLYSACCHARIDE	  OF	  SALMONELLA	  ENTERICA	  
SEROVAR	  SAINTPAUL	  PLAYS	  A	  ROLE	  IN	  THE	  INDUCTION	  OF	  
NONTYPHOIDAL	  SALMONELLA	  ENCEPHALOPATHY	  IN	  THE	  BOVINE	  	  	  ABSTRACT	  Calves	  infected	  with	  Salmonella	  enterica	  serovar	  Saintpaul	  (SstpNPG)	  can	  result	  in	  nontyphoidal	  Salmonella	  encephalopathy	  (NTSE),	  which	  produces	  such	  signs	  as	  head	  tilt,	  ataxia,	  seizures,	  and	  ear	  fluttering.	  	  Glutamate	  was	  recently	  established	  to	  be	  the	  element	  provoking	  these	  signs	  of	  neurologic	  disease	  but	  it	  is	  unknown	  what	  is	  perpetuating	  its	  release.	  	  SstpNPG	  becomes	  quiescent	  once	  inside	  the	  brain,	  suggesting	  the	  lipopolysaccharide	  (LPS)	  of	  the	  strain	  could	  be	  provoking	  a	  toxic	  release	  of	  glutamate.	  	  In	  order	  to	  determine	  if	  LPS	  plays	  a	  role	  in	  producing	  the	  signs	  of	  NTSE,	  in	  
vivo	  experiments	  were	  conducted	  that	  involved	  infecting	  calves	  with	  an	  LPS-­‐free	  
SstpNPG	  and	  treating	  SstpNPG-­‐infected	  calves	  with	  polymyxin,	  endoserum,	  and	  MgBioserum.	  	  Debilitating	  LPS	  abolished	  all	  signs	  of	  neurologic	  disease	  in	  calves	  infected	  with	  SstpNPG	  establishing	  a	  strong	  case	  for	  LPS	  participating	  in	  the	  release	  of	  glutamate-­‐invoked	  NTSE.	  	  INTRODUCTION	  	   A	  neuropathogenic	  isolate	  of	  Salmonella	  enterica	  serovar	  Saintpaul	  (SstpNPG)	  that	  was	  first	  isolated	  from	  a	  4-­‐month	  old	  calf	  has	  been	  studied	  in	  order	  to	  better	  understand	  the	  mechanism	  at	  which	  it	  can	  provoke	  nontyphoidal	  Salmonella	  encephalopathy	  (NTSE).	  	  NTSE,	  which	  manifests	  as	  head	  tilt,	  ataxia,	  seizures,	  ear	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fluttering,	  and	  other	  neurologic	  signs,	  rarely	  occurs	  because	  few	  nontyphoidal	  
Salmonella	  are	  capable	  of	  crossing	  into	  the	  brain.	  	  SstpNPG	  has	  been	  recently	  determined	  to	  penetrate	  the	  blood-­‐brain	  barrier	  (BBB)	  paracellularly	  through	  the	  expression	  of	  collagenase	  gene	  (clg).	  	  Interestingly,	  clg	  is	  typically	  repressed	  and	  previous	  work	  demonstrated	  that	  bovine	  neuroendocrine	  hormones	  were	  capable	  of	  activating	  the	  expression	  of	  the	  gene	  but	  porcine	  neuroendocrine	  hormones	  were	  incapable	  of	  exerting	  similar	  effects	  [28].	  	  	  	   Previous	  work	  indicates	  that	  glutamate	  is	  at	  play	  –	  blocking	  N-­‐methyl-­‐D-­‐aspartic	  acid	  receptor	  (NMDAR)	  and	  increasing	  glutamate	  transporter	  -­‐1	  (GLT-­‐1)	  expression	  abolished	  signs	  of	  neurologic	  disease	  in	  calves.	  	  Also,	  a	  glutamate	  transporter	  inhibitor,	  threo-­‐beta-­‐hydroxyaspartate	  (THA),	  reversed	  the	  neuroprotective	  effects	  of	  beta-­‐lactam	  antibiotics	  that	  increase	  GLT-­‐1	  expression.	  	  Interestingly,	  treating	  calves	  that	  received	  a	  nonpathogenic	  strain	  of	  S.	  Saintpaul	  (SstpSARB)	  with	  THA	  did	  not	  result	  in	  signs	  of	  neurologic	  disease.	  	  The	  aforementioned	  strongly	  signifies	  that	  a	  toxic	  release	  of	  glutamate	  occurs	  with	  SstpNPG	  infection.	  	  	   Excess	  release	  of	  glutamate	  is	  associated	  with	  such	  neurodegenerative	  diseases	  as	  Alzheimer’s	  disease,	  amyotrophic	  lateral	  sclerosis,	  Parkinson’s	  disease	  and	  Huntington’s	  disease	  [1,	  3,	  4,	  7,	  18,	  21].	  	  Aberrations	  in	  glutamate	  exportation	  via	  glutamate	  transporters	  can	  also	  result	  in	  neurodegenerative	  diseases	  [4,	  14].	  	  Therefore,	  glutamate	  is	  likely	  the	  candidate	  responsible	  for	  producing	  neurotoxic-­‐like	  effects	  in	  calves	  suffering	  from	  NTSE.	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Once	  SstpNPG	  traverses	  the	  BBB,	  however,	  little	  is	  known	  about	  the	  activities	  that	  activate	  glutamate-­‐based	  saturation	  NTSE.	  	  	  It	  has	  been	  established	  that	  the	  neurological	  deficits	  seen	  in	  calves	  infected	  with	  SstpNPG	  do	  not	  result	  from	  bacteremia	  in	  cerebrovasculature	  or	  brain	  abcessation	  since	  only	  one	  CFU	  per	  10	  grams	  can	  be	  isolated	  from	  the	  brains	  of	  subjects	  [16].	  	  There	  were	  also	  no	  distinct	  differences	  observed	  when	  conducting	  a	  hematoxylin	  and	  eosin	  (H	  &	  E)	  stain	  of	  the	  brain	  [16].	  	  Previous	  work	  also	  determined	  that	  once	  SstpNPG	  penetrates	  the	  BBB,	  it	  becomes	  transcriptionally	  inactive	  inside	  the	  brain.	  This	  indicates	  that	  whatever	  mechanisms	  are	  in	  progress	  the	  bacterial	  strain	  participates	  passively,	  highlighting	  the	  possibility	  of	  lipopolysaccharide	  (LPS)	  contributing	  to	  the	  detrimental	  release	  of	  glutamate	  in	  the	  system.	  	  LPS	  molecules	  are	  located	  in	  the	  outer	  membrane	  of	  gram-­‐negative	  bacteria	  and	  are	  composed	  of	  three	  elements:	  lipid	  A,	  O	  antigen	  and	  a	  core	  oligosaccharide	  [15,	  24,	  26].	  	  	  The	  toxic	  effects	  of	  this	  endotoxin	  are	  a	  result	  of	  the	  lipid	  A,	  which	  anchors	  the	  LPS	  to	  the	  outer	  membrane	  of	  the	  gram-­‐negative	  bacteria	  [15,	  24,	  26].	  	  	  Host	  antibodies	  typically	  recognize	  the	  O	  antigen	  of	  the	  LPS,	  which	  often	  elicits	  a	  strong	  immune	  response	  as	  a	  result	  [11,	  12].	  	  Neither	  the	  O	  antigen	  or	  core	  oligosaccharide	  is	  necessary	  for	  bacterial	  growth;	  though,	  the	  two	  aid	  in	  antibiotic	  resistance,	  the	  complement	  system,	  and	  other	  environmental	  stresses	  [24].	  	  	  In	  order	  to	  determine	  if	  the	  LPS	  of	  
SstpNPG	  plays	  a	  role	  in	  inducing	  the	  signs	  of	  neurologic	  disease	  seen	  in	  calves,	  in	  vivo	  experiments	  were	  conducted	  to	  identify	  a	  relationship	  between	  LPS	  and	  neurologic	  disease.	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MATERIALS	  AND	  METHODS	  
Bacterial	  strains	  	   SstpNPG	  was	  obtained	  from	  calves	  that	  displayed	  clinical	  signs	  of	  neuropathogenicity,	  such	  as	  head	  tilt,	  ataxia,	  auditory	  hyper-­‐responsiveness,	  partial	  blindness	  and	  ear	  fluttering	  [16].	  	  Bacteria	  were	  stored	  in	  cryopreservation	  tubes	  immersed	  in	  50%	  glycerol	  and	  50%	  Lennox	  L	  broth	  at	  -­‐80°C	  and	  were	  grown	  in	  Lennox	  L	  broth	  or	  on	  culture	  agar	  prior	  to	  use.	  	  Prior	  to	  challenge,	  SstpNPG	  was	  grown	  statically	  overnight	  for	  16	  hours	  in	  a	  nutrient	  broth	  containing	  8	  µg/mL	  of	  ceftiofur	  at	  37°C.	  	  	  In	  order	  to	  produce	  bacterial	  strains	  that	  lacked	  LPS,	  SstpNPG	  was	  grown	  in	  the	  presence	  of	  ethylenediaminetetraacetic	  acid	  (EDTA)(1	  mM	  Sigma)	  for	  2.0	  hours	  prior	  to	  inoculation.	  	  EDTA	  is	  known	  to	  sequester	  the	  divalent	  cations	  (Mg2+	  and	  Ca2+)	  of	  the	  LPS	  thereby	  affecting	  the	  structural	  integrity	  and	  relinquishing	  SstpNPG	  of	  LPS	  [2].	  
In	  vivo	  experiment	  	   Subjects	  were	  1-­‐	  to	  5-­‐week-­‐old	  calves	  with	  an	  average	  weight	  of	  50	  kg.	  	  All	  animals	  were	  inoculated	  orally	  with	  4.5	  X	  106	  CFUs/kg	  of	  SstpNPG	  except	  for	  three	  calves	  that	  were	  orally	  challenged	  with	  4.5	  X	  106	  CFUs	  per	  kilogram	  of	  SstpNPG	  that	  had	  been	  treated	  with	  EDTA.	  	  In	  order	  to	  pharmacologically	  produce	  stress,	  each	  subject	  received	  daily	  injections	  of	  norepinephrine	  (45	  µg/kg,	  IM,	  Sigma)	  starting	  on	  the	  day	  of	  inoculation	  and	  continuing	  until	  the	  animals	  were	  euthanized.	  	  One	  group	  of	  three	  subjects	  received	  a	  treatment	  of	  polymyxin	  nonapeptide	  B	  (1	  mg/kg,	  IM,	  Sigma).	  	  Polymyxin	  debilitates	  the	  toxic	  effect	  of	  LPS	  by	  binding	  to	  and	  deactivating	  the	  lipid	  A	  [8,	  25].	  	  Two	  groups	  containing	  three	  subjects	  each	  received	  either	  endoserum	  (10	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mL/lb,	  1:1;	  IM,	  IMMVAC,	  Inc)	  or	  MgBioserum	  (10	  mL/lb,	  1:128;	  IM;	  MgBiologics)	  as	  a	  treatment.	  	  Both	  endoserum	  and	  MgBioserum	  contain	  anti-­‐LPS	  antibodies	  that	  recognize,	  bind	  to,	  and	  deactivate	  LPS	  [10,19,	  20].	  	  To	  serve	  as	  a	  control	  for	  calves	  displaying	  neurologic	  disease,	  three	  calves	  received	  no	  treatment,	  while	  another	  group	  of	  three	  calves	  served	  as	  a	  positive	  treatment	  control	  and	  received	  ceftiofur	  (6.6	  mg/kg,	  subcutaneous;	  Excede®,	  Pfizer).	  	  	   Subjects	  were	  observed	  for	  signs	  of	  neurological	  deficits	  such	  as	  seizures,	  excessive	  ear	  fluttering,	  ataxia,	  opisthotonus,	  and	  proprioceptive	  placing	  deficits.	  	  Once	  they	  showed	  signs	  of	  neurologic	  disease	  (typically	  4	  to	  9	  days	  after	  inoculation),	  animals	  were	  euthanized.	  	  An	  animal	  with	  neurologic	  disease	  was	  defined	  as	  an	  animal	  that	  suffered	  from	  convulsions	  or	  that	  had	  at	  least	  3	  of	  the	  aforementioned	  clinical	  signs	  of	  neurologic	  deficits.	  	  Animals	  that	  did	  not	  display	  signs	  of	  neurologic	  disease	  were	  euthanized	  10	  days	  after	  inoculation.	  	  Euthanization	  of	  animals	  was	  conducted	  with	  xylazine	  (0.45	  mg/kg,	  IM,	  Phoenix	  Laboratories)	  and	  pentobarbitol	  (1.2	  mg/kg,	  IV,	  Fort	  Dodge	  Laboratories).	  	  Animal	  experiments	  were	  approved	  by	  the	  Iowa	  State	  University	  Institutional	  Animal	  Care	  and	  Use	  Committee.	  
Bacteriologic-­based	  detection	  of	  SsptNPG	  	   Samples	  of	  the	  blood	  (10	  mL)	  and	  brain	  (10	  g)	  were	  collected	  from	  each	  animal	  for	  qualitative	  assessment	  of	  SstpNPG.	  	  Samples	  were	  cultured	  in	  a	  50	  mL	  falcon	  tube	  with	  10	  mL	  of	  LB	  broth	  with	  no	  antibiotics	  and	  grown	  statically	  overnight	  at	  37°C.	  	  In	  order	  to	  qualitatively	  assess	  the	  samples	  for	  Salmonella,	  10	  µL	  of	  the	  inoculum	  was	  plated	  onto	  a	  brilliant	  green	  sulfur	  (BGS)	  agar	  containing	  8	  µg/mL	  of	  ceftiofur	  to	  isolate	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individual	  colonies.	  	  A	  Salmonella-­‐specific	  PCR	  assay	  targeting	  the	  sipB-­sipC	  junction	  was	  conducted	  on	  individual	  colonies	  for	  identification	  [6].	  	  	  RESULTS	  	   In	  order	  to	  determine	  the	  role	  of	  LPS	  in	  producing	  the	  effects	  of	  neurological	  deficits	  seen	  in	  calves	  infected	  with	  SstpNPG,	  a	  group	  of	  calves	  were	  inoculated	  with	  LPS-­‐free	  SstpNPG	  (SstpNPG	  exposed	  to	  EDTA).	  	  EDTA	  compromises	  the	  structural	  integrity	  of	  LPS	  by	  sequestering	  divalent	  cations	  [2].	  	  Calves	  treated	  with	  LPS-­‐free	  
SstpNPG	  did	  not	  display	  signs	  of	  neurologic	  disease	  indicating	  that	  LPS	  may	  play	  a	  role	  in	  perpetuating	  the	  neurological	  effects	  (see	  Table	  1).	  	  To	  further	  test	  this,	  two	  groups	  of	  calves	  received	  treatments	  of	  endoserum	  and	  Mgbioserum	  post-­‐infection,	  which	  are	  known	  to	  bind	  to	  and	  deactivate	  LPS.	  	  As	  depicted	  in	  Table	  1,	  treatments	  of	  endoserum	  and	  MgBioserum	  were	  able	  to	  ameliorate	  the	  effects	  of	  neurologic	  disease	  in	  calves	  infected	  with	  SstpNPG.	  	  Another	  group	  of	  calves	  received	  a	  treatment	  of	  polymyxin	  nonapeptide	  B	  in	  order	  to	  further	  investigate	  the	  role	  of	  LPS	  in	  potentially	  provoking	  neurologic	  disease.	  	  Treatment	  with	  polymyxin	  nonapeptide	  B	  abolished	  the	  toxic	  effects	  of	  LPS	  by	  binding	  to	  and	  deactivating	  the	  lipid	  A	  [8,	  25].	  	  Calves	  that	  received	  polymyxin	  nonapeptide	  B	  did	  not	  show	  signs	  of	  neurologic	  disease	  (see	  Table	  1).	  	  
SstpNPG	  was	  isolated	  from	  both	  the	  blood	  and	  brain	  samples	  of	  all	  infected	  calves	  (see	  Table	  1).	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DISCUSSION	  	   LPS	  are	  significant	  pathogen-­‐associated	  molecular	  patterns	  (PAMPs)	  readily	  recognized	  by	  host	  antigens	  and	  thereby	  triggering	  a	  number	  of	  host	  immune	  responses.	  	  	  This	  endotoxin	  is	  capable	  of	  interacting	  with	  such	  receptors	  as	  Toll-­‐Like	  Receptors	  and	  CD14	  (cluster	  of	  differentiation	  14),	  which	  in	  turn	  produces	  inflammatory	  responses	  [13,	  17,	  22].	  	  Interestingly,	  calves	  infected	  with	  SstpNPG	  do	  not	  display	  abnormal	  CNS	  inflammation.	  	  It	  is	  possible	  that	  the	  LPS	  of	  SstpNPG	  may	  be	  triggering	  the	  release	  of	  glutamate	  to	  produce	  the	  signs	  of	  neurologic	  disease	  in	  calves	  through	  other	  means.	  	   In	  order	  to	  determine	  if	  LPS	  does	  play	  a	  role	  in	  the	  induction	  of	  neurologic	  disease,	  calves	  were	  infected	  with	  SstpNPG	  and	  then	  treated	  with	  pharmacological	  agents	  that	  inhibited	  the	  potential	  effects	  of	  LPS.	  	  Results	  indicate	  that	  treatment	  with	  polymyxin	  nonapeptide	  B,	  endoserum,	  and	  MgBioserum	  were	  able	  to	  ameliorate	  the	  effects	  of	  neurologic	  signs	  in	  calves	  (see	  Table	  1).	  	  Furthermore,	  calves	  treated	  with	  LPS-­‐free	  SstpNPG	  did	  not	  display	  signs	  of	  neurologic	  disease.	  	  All	  calves	  infected	  with	  
SstpNPG	  displayed	  signs	  of	  systemic	  spread	  as	  both	  the	  blood	  and	  brain	  samples	  from	  each	  subject	  contained	  SstpNPG	  isolates	  but	  only	  the	  control	  group	  of	  calves	  that	  received	  no	  treatment	  possessed	  neurological	  deficiencies.	  	  This	  indicated	  that	  despite	  the	  ability	  to	  induce	  systemic	  spread	  and	  traverse	  the	  BBB,	  the	  inhibition	  of	  the	  LPS	  definitively	  abolishes	  signs	  of	  neurologic	  disease.	  	  LPS	  may	  indeed	  play	  a	  role	  in	  perpetuating	  the	  effects	  that	  lead	  up	  to	  neurologic	  disease	  in	  calves	  infected	  with	  
SstpNPG.	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   LPS	  has	  been	  shown	  to	  trigger	  the	  release	  of	  glutamate,	  norepinephrine	  and	  adenosine	  from	  slices	  of	  rat	  parietal	  cortex	  [27].	  	  The	  rapid	  release	  of	  glutamate	  due	  to	  the	  presence	  of	  LPS	  was	  determined	  to	  be	  too	  rapid	  to	  involve	  gene	  transcription	  and	  protein	  synthesis	  and	  it	  was	  also	  shown	  to	  be	  a	  reversible	  effect	  once	  LPS	  was	  removed	  from	  the	  system	  [27].	  	  It	  was	  proposed	  that	  LPS-­‐evoked	  glutamate	  release	  may	  be	  associated	  with	  immune	  responses	  such	  as	  cytokine	  and/or	  prostanoid	  release	  and	  may	  be	  released	  through	  glial	  rather	  than	  neuronal	  cells	  [27].	  	  The	  release	  of	  adenosine	  may	  potentially	  explain	  why	  little	  inflammation	  is	  typically	  seen	  in	  calves	  infected	  with	  
SstpNPG	  since	  adenosine	  has	  been	  shown	  to	  decrease	  inflammatory	  responses	  via	  A2A	  receptors	  on	  macrophages	  and	  neutrophils	  [9].	  	   It	  is	  possible	  that	  SstpNPG	  possesses	  a	  unique	  structure	  and	  this	  possibility	  may	  give	  insight	  into	  which	  receptor	  is	  potentially	  being	  activated.	  	  Determining	  the	  uniqueness	  of	  the	  LPS	  structure	  could	  be	  established	  by	  introducing	  a	  nonpathogenic	  strain	  into	  the	  brain	  in	  vivo	  to	  determine	  if	  similar	  effects	  will	  ensue.	  	  Exposing	  calf	  brain	  to	  purified	  LPS	  could	  also	  offer	  results	  that	  could	  lead	  to	  a	  better	  understanding	  of	  the	  specificity	  of	  the	  LPS	  of	  SstpNPG	  in	  producing	  neurologic	  disease.	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CHAPTER	  6.	  GENERAL	  CONCLUSIONS	  	  	  OVERVIEW	   	  
SstpNPG	  is	  a	  unique	  isolate	  that	  is	  capable	  of	  producing	  bovine	  encephalopathy	  in	  the	  presence	  of	  host	  neuroendocrine	  hormones.	  	  Though	  this	  is	  not	  unusual	  for	  typhoidal	  and	  paratyphoidal	  strains,	  it	  is	  a	  rare	  phenomenon	  for	  nontyphoidal	  strains.	  	  In	  order	  to	  better	  understand	  SstpNPG,	  in	  vivo	  and	  in	  vitro	  molecular	  techniques	  were	  used	  to	  determine	  conditions	  underlying	  neuropathogenicity,	  to	  understand	  how	  the	  strain	  traverses	  the	  BBB,	  to	  find	  a	  potential	  pharmacological	  agent	  that	  can	  abrogate	  the	  effects	  of	  neuropathogenicity,	  and	  to	  assess	  the	  bacterial	  factors	  that	  provoke	  neurologic	  disease.	  	  HOST-­‐CONDITION	  SPECIFIC	  PHENOMENON	  	   Stressed	  calves	  affected	  by	  SstpNPG	  showed	  signs	  of	  neurologic	  disease,	  such	  as	  excessive	  ear	  fluttering	  and	  seizures.	  	  It	  is	  unknown	  whether	  these	  clinical	  findings	  are	  specific	  to	  bovine	  and	  are	  an	  indication	  of	  a	  distinct	  relationship	  between	  the	  host	  and	  the	  bacterial	  strain	  that	  induces	  nontyphoidal	  Salmonella	  encephalopathy	  (NTSE),	  which	  is	  a	  rare	  occurrence.	  	  In	  order	  to	  determine	  if	  there	  is	  a	  relationship	  between	  bovine	  and	  SstpNPG,	  both	  porcine	  and	  bovine	  subjects	  were	  inoculated	  with	  SstpNPG	  in	  order	  to	  compare	  host	  signs	  of	  disease.	  	  	  	   Norepinephrine-­‐treated	  pigs	  infected	  with	  SstpNPG	  did	  not	  show	  signs	  of	  neurologic	  disease	  or	  systemic	  infection	  whereas	  calves,	  as	  expected,	  displayed	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neurologic	  signs.	  	  These	  results	  indicate	  that	  there	  is	  a	  host	  condition-­‐specific	  relationship	  that	  perpetuates	  both	  neurologic	  disease	  and	  systemic	  infection.	  	  The	  relationship	  between	  SstpNPG	  and	  bovine	  may	  be	  more	  complex	  than	  host	  neuroendocrine	  hormone	  interactions	  since	  norepinephrine	  and	  dexamethasone	  were	  unable	  to	  provoke	  either	  neurologic	  disease	  or	  systemic	  spread	  in	  porcine.	  	  It	  is	  clear	  that	  the	  neuroendocrine	  requirements	  for	  neuropathogenicity	  are	  absent	  in	  swine.	  	  	  	  	   There	  is	  most	  likely	  a	  distinct	  relationship	  occurring	  between	  bovine	  immunologic	  response	  and	  how	  SstpNPG	  interacts	  with	  host	  factors.	  	  Bacterial	  infection	  often	  yields	  increased	  expression	  of	  cytokines,	  such	  as	  interferon	  gamma	  (IFN-­‐γ),	  interleukin-­‐10	  (IL-­‐10)	  and	  tumor	  necrosis	  factor	  alpha	  (TNF-­‐α)	  [26].	  	  Subjects	  that	  show	  higher	  levels	  of	  IFN-­‐γ/IL-­‐10	  concurrently	  showed	  higher	  levels	  of	  gross	  pathology	  [26].	  	  Cytokines	  are	  often	  responsible	  for	  the	  regulation	  of	  host	  antibodies.	  	  One	  such	  example	  is	  that	  of	  IFN-­‐γ	  regulating	  IgA,	  an	  essential	  constituent	  of	  cattle	  immune	  defense	  [7].	  	  	  The	  release	  of	  such	  cytokines	  is	  typically	  due	  to	  lipopolysaccharides	  and	  effector	  proteins	  [8,	  14,	  15,	  19,	  25,	  28].	  	  	  Better	  understanding	  of	  the	  relationship	  between	  host	  immune	  response	  and	  pathogen	  interaction	  may	  explain	  the	  signs	  of	  infection	  and	  degree	  of	  pathogen	  virulence.	  	  Protein	  secretion	  systems,	  T3SS-­‐1	  and	  T3SS-­‐2,	  are	  most	  likely	  at	  play	  as	  they	  are	  the	  primary	  elements	  for	  pathogenicity	  and	  systemic	  spread	  via	  effector	  proteins.	  	  Protein	  secretion	  systems	  are	  also	  the	  most	  prominent	  way	  bacteria	  interact	  with	  their	  environment.	  	  Further	  investigation	  is	  required	  to	  better	  understand	  the	  interaction	  between	  SstpNPG	  and	  stressed	  cattle.	  	  It	  is	  possible	  that	  experimentation	  with	  other	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host	  ruminants	  could	  lead	  to	  increased	  understanding.	  	  Therefore,	  other	  ruminants	  should	  be	  considered	  to	  see	  if	  similar	  effects	  could	  be	  observed.	  	  COLLAGENASE	  ALLOWS	  SstpNPG	  TO	  PENETRATE	  BLOOD-­‐BRAIN	  BARRIER	  	   NTSE	  is	  a	  rare	  occurrence	  due	  to	  the	  fact	  that	  bacterial	  invasion	  is	  primarily	  halted	  prior	  to	  systemic	  infection	  and	  that	  even	  fewer	  strains	  possess	  the	  ability	  to	  penetrate	  the	  BBB.	  	  Previous	  work	  has	  pinpointed	  a	  protein	  with	  cytotoxin-­‐like	  effects,	  later	  coined	  as	  collagenase	  (clg)	  due	  to	  its	  homology	  to	  a	  known	  E.	  coli	  collagenase	  [27]	  that	  may	  be	  capable	  of	  breaking	  down	  the	  tight	  junctions	  and	  the	  basement	  membrane	  of	  the	  BBB.	  	  clg	  is	  found	  in	  most	  Salmonella	  species	  and	  is	  a	  gene	  that	  is	  repressed	  under	  normal	  conditions.	  	  
clg	  is	  derepressed	  by	  bovine	  stress	  factors	  	   In	  order	  to	  determine	  if	  clg	  can	  be	  derepressed	  in	  the	  presence	  of	  stressed	  bovine	  blood,	  SstpNPG	  was	  grown	  in	  nutrient	  broth	  containing	  bovine	  serum	  from	  either	  stressed	  or	  unstressed	  cattle.	  	  To	  delineate	  the	  neuroendocrine	  hormones	  potentially	  involved,	  the	  strain	  was	  also	  grown	  in	  nutrient	  broth	  treated	  with	  norepinephrine	  or	  dexamethasone.	  	  As	  a	  control,	  SstpSARB	  was	  also	  grown	  under	  the	  same	  conditions.	  	  RT-­‐PCR	  results	  indicated	  that	  clg	  was	  only	  transcriptional	  active	  when	  grown	  in	  stressed	  bovine	  serum	  and	  was	  unable	  to	  be	  derepressed	  by	  norepinephrine	  or	  dexamethasone	  alone.	  	  Later	  studies	  indicated	  that	  exposure	  of	  
SstpNPG	  to	  both	  norepinephrine	  and	  dexamethasone	  was	  incapable	  of	  derepressing	  clg	  (data	  not	  shown).	  	  Though	  SstpSARB	  possesses	  clg,	  the	  gene	  was	  unable	  to	  be	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derepressed	  during	  any	  of	  the	  growth	  conditions.	  	  This	  indicates	  a	  unique	  relationship	  at	  play	  between	  bovine	  neuroendocrine	  factors	  and	  SstpNPG.	  	  	  	   Considering	  the	  role	  of	  clg	  in	  vitro,	  it	  is	  very	  likely	  that	  this	  protein	  is	  regulated	  by	  SPIs.	  	  SPI-­‐1	  is	  found	  in	  all	  species	  of	  S.	  enterica	  and	  is	  essential	  for	  epithelial	  cell	  invasion	  [20].	  	  Though	  the	  majority	  of	  S.	  enterica	  possess	  SPI-­‐1,	  effector	  proteins	  released	  by	  protein	  secretion	  systems	  are	  unique	  and	  vary	  from	  strain	  to	  strain.	  	  	  clg	  may	  be	  regulated	  by	  SPI-­‐1	  via	  T3SS-­‐1	  through	  the	  interaction	  with	  host	  neuroendocrine	  factors.	  	  Carlson	  and	  colleagues	  (2005)	  determined	  that	  SlyA	  represses	  the	  expression	  of	  clg	  in	  S.	  Typhimurium	  DT104.	  	  Considering	  this	  along	  with	  the	  fact	  that	  SlyA	  is	  a	  protein	  responsible	  for	  regulating	  a	  number	  of	  functions	  in	  Salmonella,	  it	  is	  worth	  pursuing	  to	  determine	  if	  this	  protein	  also	  represses	  the	  clg	  gene	  of	  SstpNPG	  [4].	  	  More	  importantly,	  further	  studies	  should	  be	  considered	  to	  determine	  what	  deactivates	  the	  repressor	  protein	  responsible	  for	  regulating	  the	  expression	  of	  clg.	  
NTSE	  requires	  production	  of	  clg	  to	  traverse	  BBB	  	   In	  vivo	  experiments	  were	  conducted	  to	  determine	  if	  there	  is	  a	  direct	  relationship	  between	  SstpNPG	  accessing	  the	  brain	  to	  that	  of	  clg	  expression.	  	  Calves	  were	  inoculated	  with	  the	  SstpNPG	  strain	  transformed	  with	  a	  plasmid	  containing	  an	  antisense	  clg	  that	  would	  transiently	  knock	  out	  clg	  expression.	  	  Another	  group	  of	  calves	  received	  SstpNPG	  as	  a	  positive	  control,	  while	  another	  set	  of	  subjects	  received	  SstpSARB	  to	  serve	  as	  a	  negative	  control.	  	  All	  three	  groups	  received	  norepinephrine	  to	  pharmacologically	  imitate	  stress.	  	  Calves	  given	  the	  strain	  with	  a	  deactivated	  clg	  did	  not	  show	  signs	  of	  neurological	  deficits	  because	  the	  knock	  down	  strain	  was	  unable	  to	  penetrate	  the	  BBB.	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This	  indicated	  that	  clg	  is	  pivotal	  for	  the	  traversal	  of	  the	  BBB	  and	  that	  the	  strain	  must	  access	  the	  brain	  to	  produce	  such	  effects.	  	  	  
clg	  allows	  for	  a	  paracellular	  route	  into	  the	  brain	  	   Pharmacologically	  tightening	  the	  BBB	  hindered	  the	  strain	  from	  entering	  the	  brain.	  	  Cilostazol	  increases	  the	  effectiveness	  of	  tight	  junctions	  by	  selectively	  inhibiting	  phosphodiesterase	  III,	  the	  enzyme	  responsible	  for	  breaking	  down	  cyclic	  adenosine	  monophosphate	  (cAMP).	  	  Increased	  levels	  of	  intracellular	  cAMP	  have	  been	  shown	  to	  hinder	  the	  paracellular	  route	  into	  the	  brain	  by	  increasing	  tight	  junction	  complexes	  of	  the	  BBB	  [1].	  	  This	  indicates	  that	  the	  production	  and	  release	  of	  clg	  by	  SstpNPG	  results	  in	  a	  paracellular	  permeability	  of	  the	  BBB.	  	   	  	  	  	  	  	  	  BETA-­‐LACTAM	  ANTIBIOTICS	  AMELIORATE	  NEUROLOGIC	  DISEASE	  	   Calves	  infected	  with	  SstpNPG	  displayed	  signs	  of	  neurologic	  disease	  that	  included	  diarrhea,	  head	  tilt,	  ataxia,	  auditory	  hyper-­‐responsiveness,	  and	  partial	  blindness.	  	  Incidentally,	  this	  form	  of	  bovine	  encephalopathy	  results	  in	  no	  detectable	  histopathologic	  changes	  in	  the	  central	  nervous	  system	  (i.e.,	  neuroinflammation)	  using	  standard	  techniques	  such	  as	  hematoxylin	  and	  eosin	  (H&E)	  staining	  [16].	  	  McCuddin	  and	  colleagues	  (2008)	  also	  observed	  that	  only	  one	  CFU	  per	  10	  grams	  of	  calf	  brain	  could	  be	  isolated	  elucidating	  that	  the	  neurological	  deficits	  most	  likely	  result	  from	  Salmonella-­‐mediated	  neurochemical	  abnormalities	  that	  were	  undetectable	  by	  standard	  histopathological	  practices.	  	  A	  possible	  candidate	  is	  the	  primary	  neurochemical	  excitatory	  transmitter,	  glutamate.	  	  Excitotoxicity	  can	  result	  from	  an	  oversaturation	  of	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calcium	  influx	  due	  to	  increased	  activation	  of	  glutamate	  receptors.	  	  Increased	  calcium	  activity	  can	  cause	  excitotoxicity	  by	  triggering	  the	  activation	  of	  enzymes	  such	  as	  phospholipases,	  endonucleases,	  and	  proteases	  [12].	  	  	  
Beta-­lactam	  antibiotics	  serve	  as	  a	  viable	  neuroprotective	  agent	  	   There	  are	  five	  glutamate	  transporters	  responsible	  for	  the	  uptake	  of	  glutamate	  from	  the	  extracellular	  space:	  GLAST	  (EAAT1),	  GLT-­‐1	  (EAAT3),	  EAAC1	  (EAAT3),	  EAAT4	  and	  EAAT5.	  	  GLT-­‐1	  is	  the	  primary	  transporter	  that	  protects	  both	  neurons	  and	  glial	  cells	  from	  excitotoxicity	  and	  is	  located	  on	  glial	  and	  endothelial	  cells	  [11,	  17,	  22,	  23].	  	  Dysfunction	  of	  GLT-­‐1	  is	  associated	  with	  neurodegenerative	  diseases	  like	  amyotrophic	  lateral	  sclerosis	  and	  strokes	  [5,	  10,	  18].	  	  Glutamate	  toxicity	  has	  also	  been	  associated	  with	  Alzheimer’s	  disease	  and	  Huntington’s	  disease	  [2,	  3].	  	  In	  2005,	  Rothstein	  and	  colleagues	  determined	  that	  beta-­‐lactam	  antibiotics,	  such	  as	  ceftriaxone,	  can	  serve	  as	  effective	  neuroprotective	  agents	  by	  increasing	  the	  expression	  of	  GLT-­‐1	  in	  a	  dose-­‐	  and	  concentration-­‐dependent	  manner.	  	   In	  order	  to	  determine	  the	  ability	  of	  beta-­‐lactam	  antibiotics	  to	  abolish	  signs	  of	  neurologic	  disease	  in	  calves,	  subjects	  infected	  with	  SstpNPG	  were	  also	  treated	  with	  ampicillin	  or	  ceftiofur,	  which	  are	  two	  beta-­‐lactam	  antibiotics	  that	  are	  FDA-­‐approved	  for	  use	  in	  cattle.	  	  To	  compare	  to	  non-­‐beta-­‐lactam	  antibiotics,	  enrofloxacin	  and	  minocycline	  were	  also	  given	  to	  other	  subjects	  to	  determine	  the	  effectiveness	  of	  the	  varying	  mechanisms	  of	  action	  for	  each	  pharmacological	  agent.	  	  Calves	  given	  beta-­‐lactam	  antibiotics	  were	  able	  to	  ameliorate	  effects	  of	  neurologic	  disease	  despite	  the	  strain	  showing	  in	  vitro	  resistance	  to	  these	  drugs,	  which	  was	  confirmed	  with	  Salmonella	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isolates	  from	  the	  brain.	  	  Subjects	  treated	  with	  enrofloxacin	  also	  did	  not	  display	  neurological	  deficits,	  which	  resulted	  from	  the	  bactericidal	  effects	  of	  the	  antibiotics	  as	  confirmed	  by	  the	  inability	  to	  isolate	  Salmonella	  from	  either	  blood	  or	  brain	  samples.	  	  	  Treatment	  with	  minocycline	  was	  ineffective	  despite	  the	  proposed	  neuroprotective	  effects	  of	  the	  drug.	  	  Minocycline	  blocks	  caspase-­‐1	  and	  caspase-­‐3,	  thereby	  hindering	  apoptosis	  of	  cells	  [13,	  29].	  	  It	  is	  possible	  that	  the	  neurological	  deficits	  seen	  in	  calves	  infected	  with	  SstpNPG	  are	  not	  due	  to	  neuronal	  apoptosis	  but	  rather	  necrosis.	  	  Due	  to	  the	  limitations	  on	  how	  long	  the	  subjects	  can	  be	  maintained	  with	  neurologic	  disease,	  it	  is	  difficult	  to	  see	  the	  full	  effects	  of	  SstpNPG.	  	  Further	  investigation	  needs	  to	  be	  conducted	  to	  determine	  the	  physiological	  and	  phenotypical	  effects	  of	  the	  strain	  on	  calf	  brain.	  
Glutamate	  plays	  a	  role	  in	  neurologic	  disease	  	   To	  further	  investigate	  the	  role	  of	  glutamate	  in	  this	  model,	  threo-­‐beta-­‐hydroxyaspartate	  (THA)	  was	  also	  given	  to	  calves	  that	  were	  inoculated	  with	  SstpNPG	  and	  either	  treated	  with	  ampicillin	  or	  ceftiofur.	  	  THA	  is	  a	  glutamate	  transporter	  inhibitor	  that	  specifically	  blocks	  EAAT1-­‐3.	  	  As	  a	  control,	  another	  group	  of	  calves	  were	  inoculated	  with	  the	  non-­‐pathogenic	  strain	  (SstpSARB)	  and	  treated	  with	  THA.	  	  Both	  groups	  were	  also	  given	  norepinephrine	  to	  imitate	  stress.	  	  Results	  demonstrated	  that	  THA	  was	  able	  to	  reverse	  the	  neuroprotective	  effects	  of	  beta-­‐lactam	  antibiotics,	  further	  demonstrating	  that	  glutamate	  removal	  is	  critical	  for	  abolishing	  the	  signs	  of	  neurologic	  disease.	  	  Interestingly,	  blocking	  EAAT1-­‐3	  with	  THA	  in	  the	  control	  group	  (subjects	  inoculated	  with	  SstpSARB)	  was	  unable	  to	  reproduce	  the	  neurological	  deficiencies	  seen	  in	  stressed	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calves	  infected	  with	  SstpNPG.	  	  This	  demonstrates	  that	  there	  is	  an	  excess	  release	  of	  glutamate	  in	  the	  system.	  	  It	  would	  be	  beneficial	  to	  assay	  the	  release	  of	  glutamate	  in	  subjects	  infected	  with	  the	  neuropathogenic	  strain	  when	  stressed	  to	  compare	  the	  quantity	  of	  glutamate	  with	  that	  of	  normally	  functioning	  subjects.	  	  However,	  it	  may	  be	  challenging	  to	  monitor	  free	  glutamate	  versus	  stored	  glutamate	  in	  vivo.	  	  	  
Beta-­lactam	  antibiotics	  are	  neuroprotective	  through	  increased	  GLT-­1	  expression	  	   To	  confirm	  that	  the	  neuroprotective	  effects	  of	  beta-­‐lactam	  antibiotics	  are	  a	  result	  of	  increased	  GLT-­‐1	  expression,	  a	  semi-­‐quantitative	  RTPCR	  was	  conducted	  whereby	  GLT-­‐1	  transcripts	  were	  PCR-­‐amplified	  for	  10	  cycles	  and	  40	  cycles	  from	  brain	  samples	  extracted	  from	  subjects	  inoculated	  with	  SstpNPG	  that	  received	  no	  treatment	  and	  from	  subjects	  inoculated	  with	  SstpNPG	  that	  received	  either	  ampicillin	  or	  ceftiofur.	  	  No	  differences	  were	  seen	  at	  40	  cycles	  but	  at	  10	  cycles	  subjects	  given	  beta-­‐lactam	  antibiotics	  showed	  an	  increased	  expression	  of	  GLT-­‐1	  confirming	  that	  neuroprotection	  occurs	  through	  increased	  GLT-­‐1	  expression.	  	  	  	  LIPOPOLYSACCHARIDES	  PROVOKE	  NEUROLOGIC	  DISEASE	  	   Once	  inside	  the	  brain,	  little	  is	  known	  on	  the	  mechanisms	  underlying	  the	  glutamate	  release	  elicited	  by	  SsptNPG.	  	  McCuddin	  and	  colleagues	  (2008)	  established	  that	  the	  neurologic	  signs	  seen	  in	  infected	  calves	  are	  not	  a	  result	  of	  colonization	  since	  they	  were	  only	  able	  to	  isolate	  one	  CFU	  per	  10	  grams	  of	  brain.	  	  They	  were	  also	  unable	  to	  establish	  any	  phenotypic	  anomalies	  of	  the	  brain	  through	  standard	  histopathologic	  techniques.	  	  Theoretically,	  the	  strain	  could	  be	  perpetuating	  glutamate	  release	  either	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directly	  or	  indirectly	  by	  interacting	  with	  receptors	  that	  may	  trigger	  a	  signal	  transduction	  effect	  as	  we	  have	  established	  that	  blocking	  NMDAR	  with	  MK801	  abolishes	  neurologic	  disease	  and	  that	  increasing	  the	  expression	  of	  GLT-­‐1	  ameliorates	  the	  effects	  of	  neurologic	  disease.	  	  LPS	  is	  a	  potential	  candidate	  since	  it	  is	  located	  on	  the	  outer	  membrane	  of	  gram-­‐negative	  bacteria	  like	  SstpNPG	  and	  can	  readily	  interact	  with	  host	  environment	  including	  certain	  receptors	  like	  toll-­‐like	  receptors	  (TLRs)	  and	  CD14	  [9,	  13,	  21].	  	  	  
LPS	  plays	  a	  role	  in	  the	  induction	  of	  neurologic	  disease	  	   What	  led	  to	  the	  hypothesis	  that	  LPS	  may	  be	  a	  potential	  factor	  in	  provoking	  the	  release	  of	  glutamate,	  which	  in	  turn	  is	  producing	  neurologic	  deficits	  in	  calves,	  is	  the	  status	  of	  clg	  once	  the	  strain	  is	  inside	  the	  brain.	  	  An	  RTPCR	  assay	  conducted	  on	  SstpNPG	  isolates	  from	  calf	  brain	  indicated	  that	  clg	  was	  transcriptionally	  inactive	  once	  the	  bacteria	  passed	  into	  the	  brain	  (See	  Appendix	  1).	  	  	  This	  work	  also	  demonstrated	  that	  
SstpNPG	  becomes	  quiescent	  once	  inside	  the	  brain,	  demonstrated	  by	  the	  fact	  that	  brain	  isolates	  were	  PCR	  positive	  for	  sipB-­C,	  a	  gene	  complex	  found	  in	  all	  pathogenic	  
Salmonella,	  but	  tested	  RTPCR	  negative	  for	  sipB-­C.	  	  This	  implies	  that	  the	  neurologic	  effects	  of	  SstpNPG	  on	  calves	  are	  a	  result	  of	  a	  passive	  act,	  making	  LPS	  a	  highly	  feasible	  candidate.	  	   In	  order	  to	  determine	  if	  LPS	  plays	  a	  role	  in	  producing	  the	  effects	  of	  neurologic	  disease,	  a	  group	  of	  calves	  were	  inoculated	  with	  LPS-­‐free	  SstpNPG	  resulting	  from	  exposure	  of	  ethylenediaminetetraacetic	  acid	  (EDTA).	  	  EDTA	  destabilizes	  LPS	  by	  sequestering	  divalent	  cations,	  Mg2+	  and	  Ca2+,	  thereby	  compromising	  the	  structural	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integrity	  of	  the	  lipoglycan.	  	  Two	  groups	  of	  calves	  were	  also	  infected	  with	  SstpNPG	  and	  then	  given	  either	  endoserum	  or	  MgBioserum,	  which	  contain	  anti-­‐LPS	  antibodies	  that	  bind	  to	  and	  inactivate	  LPS.	  	  Another	  group	  infected	  with	  SstpNPG	  were	  also	  treated	  with	  polymyxin	  nonapeptide	  B,	  an	  antibiotic	  that	  functions	  similarly	  to	  a	  detergent	  by	  disrupting	  the	  structure	  of	  the	  bacterial	  cell	  membrane	  specifically	  through	  binding	  the	  lipid	  A	  component	  and	  thereby	  inactivating	  the	  toxic	  effects	  of	  LPS	  [6,	  24].	  	  Results	  demonstrated	  that	  debilitating	  the	  LPS	  of	  SsptNPG	  effectively	  abrogates	  neurologic	  disease	  in	  calves.	  	  This	  denotes	  that	  LPS	  may	  be	  pivotal	  to	  the	  induction	  of	  neurologic	  disease	  by	  directly	  or	  indirectly	  releasing	  glutamate,	  the	  element	  responsible	  for	  causing	  deficiencies	  seen	  in	  infected	  calves.	  
Potential	  role	  of	  LPS	  in	  producing	  neurologic	  signs	  LPS	  is	  one	  of	  the	  most	  important	  pathogen-­‐associated	  molecular	  patterns	  (PAMPs).	  	  This	  lipoglycan	  endotoxin	  is	  often	  associated	  with	  triggering	  a	  majority	  of	  host	  immune	  responses	  particularly	  through	  the	  interaction	  with	  a	  number	  of	  receptors	  such	  as	  Toll-­‐Like	  Receptors	  and	  CD14	  (cluster	  of	  differentiation	  14)[9,	  13,	  21].	  	  Interestingly,	  these	  two	  receptors	  are	  typically	  associated	  with	  inflammatory	  responses,	  which	  were	  unable	  to	  be	  seen	  in	  calves	  infected	  with	  SsptNPG.	  	  This	  indicates	  that	  LPS	  could	  be	  potentially	  interacting	  with	  another	  type	  of	  receptor	  capable	  of	  being	  activated	  by	  lipid	  ligands.	  	  SstpNPG	  may	  also	  possess	  a	  unique	  LPS	  that	  confers	  neuropathogenicity.	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FUTURE	  DIRECTIONS	  So	  far,	  it	  has	  been	  established	  that	  SstpNPG	  traverses	  the	  BBB	  by	  releasing	  collagenase-­‐like	  protein	  expressed	  by	  clg	  that	  is	  derepressed	  by	  host	  neuroendocrine	  hormones.	  	  	  Once	  inside,	  the	  strain	  –	  though	  transcriptionally	  inactive	  –	  is	  potentially	  recognized	  by	  host	  factors	  (perhaps	  by	  a	  lipid	  activated	  receptor)	  via	  LPS.	  	  This	  potentially	  leads	  to	  an	  increase	  of	  glutamate	  release,	  which	  then	  triggers	  the	  effects	  of	  neurologic	  deficiencies	  seen	  in	  calves.	  	  Beta-­‐lactam	  antibiotics,	  though	  ineffective	  against	  the	  strain	  due	  to	  antibiotic	  resistance,	  are	  able	  to	  ameliorate	  such	  effects	  as	  ataxia,	  head	  tilt,	  and	  seizures	  by	  increasing	  the	  expression	  of	  GLT-­‐1.	   	  
Investigating	  the	  effects	  of	  traversing	  the	  BBB	  	   Since	  it	  is	  not	  entirely	  known	  how	  the	  strain	  is	  producing	  the	  effects	  seen	  in	  stressed	  calves,	  it	  would	  be	  of	  interest	  to	  determine	  if	  the	  observed	  effects	  are	  unique	  to	  the	  strain,	  indicative	  of	  the	  host	  response,	  or	  possibly	  a	  result	  of	  both	  elements.	  	  A	  possible	  approach	  is	  to	  make	  the	  BBB	  more	  permeable	  and	  inoculate	  the	  calf	  brain	  with	  a	  nonpathogenic	  strain	  of	  Sstp	  to	  observe	  the	  effects	  of	  the	  invasion.	  	  Targeting	  PDE3	  or	  adenylate	  cyclase	  in	  order	  to	  decrease	  cAMP	  concentrations	  could	  pharmacologically	  alter	  the	  BBB.	  	  Once	  stronger	  understanding	  of	  the	  regulatory	  proteins	  controlling	  clg	  is	  achieved,	  perhaps	  activating	  this	  silent	  gene	  can	  perpetuate	  a	  nonpathogenic	  strain	  to	  cross	  into	  the	  brain	  to	  compare	  effects	  to	  that	  of	  SstpNPG.	  
Determining	  the	  role	  of	  LPS	  	   The	  results	  found	  depict	  that	  LPS	  plays	  a	  role	  in	  inducing	  the	  effects	  of	  neurologic	  disease.	  	  However,	  it	  is	  unknown	  if	  these	  effects	  are	  a	  result	  of	  a	  potentially	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unique	  LPS	  composition	  or	  simply	  due	  to	  the	  presence	  of	  LPS.	  	  To	  better	  understand	  this,	  an	  LPS	  extraction	  from	  SstpNPG,	  SstpSARB,	  and	  purified	  LPS,	  which	  would	  then	  be	  put	  into	  calves,	  could	  give	  better	  insight.	  	  This	  would	  allow	  an	  improved	  understanding	  of	  the	  LPS	  specific	  to	  SstpNPG.	  	  It	  would	  also	  be	  beneficial	  to	  determine	  if	  the	  biosynthesis	  of	  the	  LPS	  varies	  from	  that	  of	  the	  nonpathogenic	  S.	  Saintpaul	  strain.	  	  A	  number	  of	  enzymes	  responsible	  for	  the	  biosynthesis	  of	  LPS	  were	  cloned	  and	  sequenced	  to	  determine	  genetic	  variance	  and	  resulted	  in	  little	  conclusion	  as	  no	  difference	  could	  be	  found	  in	  the	  following	  genes:	  galE,	  murE,	  waaL	  (rfaL),	  waaJ	  (rfaJ),	  gne,	  and	  MsbB.	  	  Though	  there	  are	  more	  genes	  involved	  in	  the	  biosynthesis	  of	  LPS,	  it	  is	  possible	  that	  variation	  between	  the	  pathogenic	  and	  nonpathogenic	  strain	  can	  be	  found.	  	  Determining	  the	  structure	  of	  LPS	  will	  offer	  a	  better	  understanding	  of	  its	  role	  in	  causing	  neurologic	  disease	  in	  calves.	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APPENDIX.	  TRANSCRIPTIONAL	  ACTIVITY	  OF	  CLG	  INSIDE	  THE	  
BRAIN	  	  	  	   01	  	  	  	  	  02	  	  	  	  	  03	  	  	  	  04	  	  	  	  	  	  	  	  	  	  	  05	  	  	  06	  	  	  	  07	  	  	  	  08	  	  	  	  09	  
	  	  	  	  The	  image	  is	  an	  RTPCR	  cloning	  for	  clg	  that	  shows	  collagenase	  is	  only	  transcriptionally	  active	  in	  Salmonella	  isolated	  from	  the	  blood	  (lane	  01	  –	  04)	  but	  not	  from	  the	  brain	  (lane	  05-­‐08)	  as	  depicted	  when	  compared	  to	  the	  positive	  control	  (lane	  09).	  	  This	  alludes	  to	  the	  strain	  becoming	  dormant	  after	  passage	  into	  the	  brain.	  	  	  	  	   	  	  	  	  
